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ABSTRACT 
 
 
EXERCISE MITIGATES THE EFFECTS OF HYPERHOMOCYSTEINEMIA 
ON ADVERSE SKELETAL MUSCLE REMODELING 
 
Lee Winchester 
 
August 3, 2015 
 
Background: Hyperhomocysteinemia (HHcy) is heavily implicated in diabetes 
and cardiovascular disease. HHcy is known for causing inflammation and 
vascular remodeling, particularly through production of reactive oxygen species 
(ROS) and matrix metalloproteinase-9 (MMP-9). Although its impact on skeletal 
muscle is rather unclear, HHcy is known to cause skeletal muscle weakness and 
functional impairment. The impact of HHcy on inflammation makes it seem likely 
that HHcy causes skeletal muscle fibrosis through induction of inflammatory 
factors and destructive macrophages. Exercise has been shown to reduce 
homocysteine levels and therefore, could serve as a promising intervention for 
HHcy. The purpose of this study was to investigate whether HHcy causes 
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skeletal muscle fibrosis through induction of inflammation and determine if 
exercise can mitigate these effects.  
Methods: For these experiments we used J774A.1 and Raw 264.7 macrophages 
in cell culture and C57, CBS+/-, FVB, MMP-9 -/-, and CBS/MMP-9 double KO 
mice for animal models. A 6 week treadmill exercise protocol was used as 
intervention for HHcy. Arterial blood pressure measures were taken through tail-
cuff method. Hind limb perfusion was measure via laser Doppler. Plasma Hcy 
estimations were measured thorugh dot blot. Measurement of skeletal muscle or 
macrophage protein expression occurred through the use of western blot, 
immunocytochemistry or immunohistochemistry. Levels of skeletal muscle mRNA 
expression were determined through PCR and qPCR. Collagen deposition in the 
skeletal muscle was measured using Masson’s trichrome staining. ROS 
production in macrophages was measured using a DCFDA assay.  
 
Results: In CBS+/- mice, increased plasma Hcy levels were associated with 
decreased body weight and muscle mass, femoral artery perfusion, femoral 
artery lumen diameter and oxidative metabolism. These mice displayed 
increased wall to lumen ratio, mean arterial blood pressure, collagen deposition 
and elevated myostatin protein expression. It was determined that CBS/MMP-9 
mice did not display any of these conditions. Exercise was capable of mitigating 
all of these effects in CBS +/- mice.  
Skeletal muscle from CBS+/- mice had elevated markers of inflammation 
and hypoxia including VEGF, iNOS, EMMPRIN, MMP-9, and IL-1β. Cell culture 
viii 
 
studies determined that Hcy caused macrophages to shift towards a destructive, 
M1 phenotype as indicated by elevated CD40, ROS, EMMPRIN and MMP-9 
production. EMMPRIN inhibition prevented induction of CD40 and ROS. In CBS 
+/- mice, it was determined that HHcy causes increased elevations in F4/80 and 
TNF-α expression, which are indicative of M1 macrophages. Exercise was 
capable of reducing the M1 macrophage population.  
 
Conclusions: We conclude that HHcy causes skeletal muscle fibrosis through 
induction of MMP-9 and M1 macrophages. Exercise is capable of mitigating the 
pathologies associated with HHcy.   
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CHAPTER I 
INTRODUCTION 
 
Homocysteine (Hcy) is a non-protein forming, non-essential amino acid 
that is derived from methionine.  Homocysteine is normally present in healthy, 
human plasma, but high levels of plasma Hcy, termed Hyperhomocysteinemia 
(HHcy), has been strongly associated with diseases such as diabetes mellitus, 
cardiovascular diseases and skeletal muscle dysfunction.   It is well established 
that HHcy is directly correlated with aortic stiffness, decreased renal function, 
endothelial dysfunction and hypertension (Bortolotto et al., 1999; Givvimani, 
Pushpakumar, Veeranki, & Tyagi, 2014; Naess, Nyland, Idicula, & Waje-
Andreassen, 2013; Sutton-Tyrrell, Bostom, Selhub, & Zeigler-Johnson, 1997; 
Wiernicki, Millo, Safranow, Gorecka--Szyld, & Gutowski, 2011).   However, more 
recent evidence suggests that HHcy also causes damage to skeletal muscle. 
Studies have shown that HHcy is strongly correlated with decreased muscle 
strength and functional limitations as well as skeletal muscle damage (Miller et 
al., 2000; Swart et al., 2013; S. Veeranki, Winchester, & Tyagi, 2015).  Children 
and animals born with a mutation that causes hyperhomocysteinemia due to the 
inability to properly metabolize homocysteine display lower body weights and 
decreased muscle mass compared to their healthy counterparts (Kalra, Ghose, & 
Sood, 1985; Kanwar, Manaligod, & Wong, 1976). 
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Many years of research on HHcy have sought to determine the 
mechanisms through which it causes these deleterious effects. The ability of 
HHcy to induce high levels of reactive oxygen species (ROS) indicates that Hcy 
may inflict a great deal of damage through increased oxidative stress and 
inflammation (Hayden & Tyagi, 2004; Signorello et al., 2007; S. C. Tyagi, 
Lominadze, & Roberts, 2005).  HHcy is also known to increase the expression 
and activity of matrix metalloproteinases (MMP), particularly MMP-9 (Seung Jin 
Lee et al., 2012; Moshal et al., 2006; Neetu Tyagi et al., 2009).  MMP-9 is an 
endoproteinase that degrades components of the extracellular matrix (ECM). 
This degradation of the ECM can lead to adverse remodeling in muscle tissues.  
It is commonly known that macrophages play a pivotal role in the 
inflammatory response and the progression of diseases such as atherosclerosis. 
More recent evidence has suggested that HHcy may have an effect on 
macrophage migration and function as well. Research has demonstrated that 
HHcy increases macrophage expression of MMP-9, vascular endothelial growth 
factor (VEGF) and monocyte chemoattractant protein-1 or MCP-1 (Kiriakidis et 
al., 2003; Seung Jin Lee et al., 2012; Wang, Siow, & Karmin, 2001). The ability of 
Hcy to alter the expression of certain macrophage proteins may evolve as 
another central mechanism through which HHcy causes disease progression.  
The concept that regular exercise provides healthful benefits and plays a 
rather ubiquitous role in the prevention and reversal of many diseases is rather 
concrete. However, the effect of regular exercise on HHcy is not very well 
established. Recent studies have demonstrated that exercise can lower plasma 
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homocysteine levels and mitigate the adverse effects of HHcy in many organs 
(Hrncic et al., 2013; König et al., 2003; Neuman, Albright, & Schalinske, 2013; 
Randeva et al., 2002; Vincent, Bourguignon, & Vincent, 2006). In the current 
study, we investigated the effects of HHcy on skeletal muscle remodeling and 
inflammation as well as the ability of exercise to attenuate these effects.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 
 
CHAPTER II 
BACKGROUND 
 
Skeletal Muscle 
Function of Skeletal Muscle 
Skeletal muscle is a high-energy consuming tissue that makes up roughly 
40 to 50% of the total bodyweight in the average human (Powers & Howley, 
2007). It consists of very long, multinucleated cells called myocytes that are 
bundled up and surrounded by connective tissues. In general, skeletal muscle 
has 2 primary functions: 1) production of contractile force that provides breathing, 
locomotion and postural support; and 2) thermogenesis during periods of cold 
stress. For force production, depending on the basic function of the muscle it 
may consist of either fast twitch (type I) fibers or slow twitch (type II) fibers 
(Powers & Howley, 2007). Type I fibers are used for repetitive, low-intensity 
functions, such as postural support. These fibers provide less force generation, 
but are fatigue resistant and have a higher reliance on oxidative metabolism and 
therefore have a greater density of mitochondria and oxidative enzymes.  Type II 
fibers can be further divided out into two fiber subsets: type IIx and type IIa 
(Powers & Howley, 2007). Type IIx fibers are very glycolytic and produce great 
contractile force, but are susceptible to fatigue due to a lower mitochondrial 
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density.  Type IIa fibers are an intermediate fiber type. They produce a moderate 
contractile force and are more fatigue resistant than Type IIx fibers.  
 
Anatomy and Physiology of Skeletal Muscle 
The outermost layer of a skeletal muscle is the epimysium, which is a 
connective tissue that surrounds the entire muscle. Inward from the epimysium is 
the perimysium, which surrounds individual bundles of myocytes, called 
fascicles. Inside of these fascicles are individual myocytes that are surrounded 
by a connective tissue called the endomysium (Powers & Howley, 2007). Just 
under the endomysium lies another protective layer called the basement 
membrane.  Below the basement membrane is the myocyte cell membrane, 
called the sarcolemma. Within the sarcolemma lies the intracellular fluid called 
sarcoplasm.  
 Myocytes, unlike most other cell types, contain multiple nuclei and are 
striated because of contractile segments called sarcomeres. Within each 
myocyte are structures called myofibrils, which contain the contractile proteins of 
the muscle, called myosin and actin (Powers & Howley, 2007). On the actin 
filament itself lies two additional proteins called troponin and tropomyosin, which 
are used for contractile regulation.  The striated regions, called sarcomeres, are 
within the myofibrils and consist of areas of myosin/actin overlap, as well as an 
area where myosin does not overlap with actin, called the H zone.  Sarcomeres 
are divided by a wall of structural proteins, which make up a region of the 
sarcomere called the Z line.  During contraction, with required energy coming 
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from the dephosphorylation of adenosine triphosphate (ATP), Myosin heads 
“cock” and form crossbridges with actin and then pivot inward towards the H 
zone. This process is called the “sliding filament theory” and is evident by the 
decrease in sarcomere length from Z line to Z line.  
 Surrounding each myofibril is a network of channels that serves as a 
storage site for calcium, which is crucial for regulation of muscular contraction 
(Powers & Howley, 2007). This structure is called the sarcoplasmic reticulum.  
The transverse tubules are another set of channels that pass through the muscle 
fiber. Each myocyte is connected to a branch of a motor neuron through a 
neuromuscular junction, which serves as the site of electrochemical 
transmission. Collectively, all of the myocytes that are innervated by a single 
motor neuron are called a motor unit.  Upon the generation of an action potential 
great enough to cause contraction, the neural impulse is transmitted to the 
myocyte through the neuromuscular junction and is propogated down the 
transverse tubules to the sarcoplasmic reticulum, causing Ca++ to be released.  
Ca++ binds to the troponin molecule, which causes a shift in tropomyosin position. 
This allows for exposure of the actin active sites and myosin-actin crossbridge 
formation, resulting in contraction. 
 
Regulation of Skeletal Muscle Growth and Repair 
 The extracellular matrix (ECM) is a non-cellular structure that provides 
physical integrity and biomechanical/biochemical support for the surrounding 
cells.  The ECM has two primary components denoted as the interstitial matrix 
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and the basement membrane (Koeppen & Stanton, 2010). These structures are 
largely made up of fibrous proteins such as collagen and elastin, which 
respectively provide rigidity and distensibility.  The interstitial matrix serves as a 
compression support for the ECM, while the basement membrane is a fibrous 
sheet that separates the surrounding cells from the connective tissues. The ECM 
is a well-regulated structure that is synthesized and degraded to allow for proper 
wound healing, growth and fibrosis.  
The extracellular matrix (ECM) of skeletal muscle is a very rigid structure 
that helps to support the high levels of mechanical stress that is placed on the 
muscle tissue. Much like the ECM’s of other cell types, skeletal muscle ECM is 
largely comprised of collagen, with collagens I and III being predominant in the 
epi-, peri- and endomysium and collagen IV being predominant in the basement 
membrane of adult skeletal muscle (Gillies & Lieber, 2011; Light & Champion, 
1984).  Typical ECM proteins such as proteoglycans, glycoproteins and matrix 
remodeling enzymes can also be found in skeletal muscle along with several 
types of mononuclear cells. Fibroblasts are the predominant type of mononuclear 
cell in the skeletal muscle ECM and are largely responsible for producing the 
majority of the ECM components such as fibronectin, collagen and MMP’s 
(Archile-Contreras, Mandell, & Purslow, 2010; Gatchalian, Schachner, & Sanes, 
1989; Kuhl et al., 1984).   
Although fibroblasts are the predominant mononuclear cell in skeletal 
muscle, macrophages are typically present in considerable number as well. 
Damaged muscle fibers attract monocytes to the site of injury through 
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chemotaxis. These monocytes switch to an anti-inflammatory profile before 
differentiating into macrophages. Upon phagocytosis of muscle cell debris, 
macrophages shift towards an anti-inflammatory profile, which causes them to 
release growth factors such as transforming growth factor -β (TGF-β) and basic 
fibroblast growth factor (bFGF), resulting in stimulation of muscle satellite cell 
migration (Arnold et al., 2007; Robertson, Maley, Grounds, & Papadimitriou, 
1993). Tissue injury causes significant increases in macrophage infiltration 2 
days post injury and a substantially greater increase after 3 days. However, 
these levels begin to subside by day 6 (Pimorady‐Esfahani, Grounds, & 
McMenamin, 1997).  Research suggests that macrophages are rather crucial for 
skeletal muscle growth and repair.  Inflammatory macrophages stimulate 
myogenic cell proliferation, while anti-inflammatory macrophages stimulate 
myogenic cell differentiation into myotubes (Arnold et al., 2007). Complete 
removal of macrophages after muscular injury hinders the repair process and 
decreases the diameter of regenerating muscle fibers. 
 
Myostatin and Follistatin 
Tissue growth and repair is tightly regulated by factors secreted by the 
skeletal muscle (myokines) as well. Myostatin, a member of the transforming 
growth factor –β (TGF-β) superfamily, is a myokine that is well-known for its 
ability to inhibit muscular growth. It has been demonstrated that hindlimb 
unloading induced muscular atrophy in mice resulted in elevated myostatin levels 
that were apparent after 1 day in the gastrocnemius muscle (Carlson, Booth, & 
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Gordon, 1999). Reisz-Porszasz et al. demonstrate that myostatin over-
expressing mice exhibit decreased bodyweight, muscle mass, myonuclear 
number and muscle fiber cross sectional area in the quadriceps, gastrocnemius 
and tibialis anterior muscles when compared to wild type (WT) controls (Reisz-
Porszasz et al., 2003). Conversely, another study by Whittemore et al. 
demonstrates that inhibition of myostatin using an antibody blockade in C57 (WT) 
male and BALB/c  female mice results in elevated quadriceps and gastrocnemius 
weights, increased total bodyweight and lean mass as well as increased grip 
strength (Whittemore et al., 2003). Research suggests that myostatin may inhibit 
muscle growth through suppression of satellite cell differentiation and myoblast 
proliferation (Joulia et al., 2003; Thomas et al., 2000; Wehling, Cai, & Tidball, 
2000). Muscle fibers with higher expression of myostatin exhibit lower satellite 
cell numbers (Wehling et al., 2000). However, it appears that myostatin inhibits 
myoblast proliferation through halting myoblast cell cycle progression in the G0 
(resting), G1 and G2 (growth) phases of the cell cycle, preventing myoblasts from 
turning into new myocytes (Joulia et al., 2003; Thomas et al., 2000).  
While myostatin serves as a direct inhibitor of muscle growth by 
preventing differentiation of satellite cells and proliferation of myoblasts, follistatin 
(Fst), an autocrine glycoprotein, is a known inhibitor of members of the TGF-β 
superfamily, including myostatin.  Lee et al. demonstrated that follistatin 
overexpressing mice exhibited dramatic increases in muscle mass that rivaled 
those of myostatin null mice (Lee & McPherron, 2001). It appears that myostatin 
elicits its inhibitory effects through binding of the activin receptor IIB (Act RIIB). 
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Follistatin not only directly binds to and inhibits myostatin, but also blocks 
myostatin signaling at the Act RIIB. Mice overexpressing a dominant negative 
form of the Act RIIB also displayed dramatic increases in weight and muscle 
mass. Similarly, Nakatani et al. utilized a mouse model that expresses a follistatin 
derived inhibitor (FSII) of myostatin that doesn’t affect activin signaling. FSII 
expressing mice exhibited substantial increases in muscle mass and strength 
compared to WT mice (Nakatani et al., 2008). When crossbred with mdx mice 
(dystrophin knockout mice), which usually display severe muscular atrophy and 
weakness, these FSII/mdx mice have elevated strength and mass compared to 
mdx mice. In mdx mice, excessive macrophage infiltration into the skeletal 
muscle is a major factor that causes adverse skeletal muscle remodeling. The 
FSII/mdx mice also display a substantial decline in macrophage number in the 
quadriceps femoris compared to mdx mice (Nakatani et al., 2008). Another study 
from Lee et al. demonstrated that follistatin heterozygous knockout mice have a 
significant reduction in muscle size and a shift towards a more oxidative fiber 
type (Lee et al., 2010). These mice have reduced myocyte cross sectional areas, 
produce less twitch force and tetanic force and exhibit impaired muscle 
remodeling in response to injury.   
 
Pathological Remodeling 
During pathological conditions, the structure of skeletal muscle can 
become adversely remodeled, causing it to become fibrotic and excessively rigid, 
preventing proper function. Skeletal muscle fibrosis is apparent in diabetes, 
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immobilization and muscular dystrophy (Alexakis, Partridge, & Bou-Gharios, 
2007; Berria et al., 2006; Duance, Stephens, Dunn, Bailey, & Dubowitz, 1980; 
Williams & Goldspink, 1984). Fibrotic muscle is characterized by increased 
collagen deposition due to elevated activity of fibroblasts, satellite cells, 
myofibers and inflammatory cells such as monocytes/macrophages.  Following 
pathological or chronic tissue injury, myostatin directly stimulates fibroblast 
activity via activin receptor IIB, causing fibroblast deposition of fibrinogen and 
collagen (McCroskery et al., 2005).  Furthermore, activated fibroblasts directly 
stimulate inflammatory macrophages through integrin receptor MAC-1, arousing 
their production of inflammatory factors such as interleukin 1-β (IL-1β) and tumor 
necrosis factor-α (TNF-α) (Vidal et al., 2008). In pathological states related to 
chronic inflammation, processes such as these continue, causing skeletal muscle 
fibrosis and dysfunction. 
  It has been well established that mdx mice, a model that represents 
muscular dystrophy in humans, display a decrease in skeletal muscle mass, 
myocyte cross sectional area and muscular strength, as well as elevated 
macrophage infiltration and muscle fibrosis (Bogdanovich et al., 2002; Desguerre 
et al., 2012; Gutpell, Hrinivich, & Hoffman, 2015; Nakatani et al., 2008).  Gutpell 
et al. demonstrate that 8 week old mdx/utrn +/- mice, which lack dystrophin and 
utrophin (another crucial protein in skeletal muscle structure), display extensive 
fibrosis in the gastrocnemius and diaphragm; while age matched mdx mice only 
displayed fibrosis in the diaphragm (Gutpell et al., 2015). Other studies suggest 
that myostatin inhibition significantly ameliorates muscular function in mdx mice, 
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producing elevated muscle weight, contractile force and cross sectional area, as 
well as attenuating macrophage infiltration into the skeletal muscle (Bogdanovich 
et al., 2002; Nakatani et al., 2008).  
  
 
Homocysteine 
Homocysteine Metabolism 
Homocysteine (Hcy) is a sulfur containing, non-essential amino acid that is 
derived from dietary methionine.  After absorption from the digestive tract, 
methionine is converted into S-adenosylmethionine (SAM) by ATP and 
methionine adenosyl triphosphate, leaving it with a transferrable methyl group.  
The methyl group is donated for normal cellular methylation requirements and 
becomes S-adenosyl-homocysteine (SAH). SAH hydrolase is an enzyme that 
reversibly hydrolyzes SAH, which produces homocysteine (Selhub, 1999).  
Homocysteine is typically metabolized through two key processes known 
as trans-sulfuration and remethylation (See Figure 1).  Through the trans-
sulfuration process, homocysteine is irreversibly converted into cystathione via 
vitamin B6 dependent enzyme Cystathione Beta Synthase (CBS).  Cystathione is 
then hydrolyzed by cystathione gamma-lyase into cysteine. This process occurs 
in the kidneys, liver, pancreas and the small intestines and allows for 
homocysteine molecules to be permanently removed from the body. However, 
through the remethylation pathway, homocysteine is remethlyated back into 
methionine by methionine synthase (MS), which depends upon folate (vitamin 
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B12) as a cofactor. MS uses N-5-methyl tetrahydrofolate (methyl-THF) as a 
methyl donor to convert homocysteine into methionine, producing THF.  THF is 
remethylated through a reaction catalyzed by methyl tetrahydrofolate reductase 
(MTHFR) back into methy-THF. This process occurs in most tissues except for 
the liver and kidneys, where betaine serves as methyl donor through a reaction 
catalyzed by betaine-homocysteine-methyltransferase (BHMT) (Selhub, 1999).   
 
 
Figure 1. Schematic representing the overview of homocysteine formation and 
metabolism. 
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Hyperhomocysteinemia 
 Homocysteine is present in healthy human plasma at a range of 5 to 15µM 
(Hillenbrand, Hillenbrand, Liewald, & Zimmermann, 2008). 
Hyperhomocysteinemia (HHcy) is a condition where plasma Hcy levels become 
>15µM/L.  HHcy has been implicated as a potential cause of numerous disease 
states such as hypertension, stroke, cardiovascular disease, and skeletal muscle 
dysfunction. HHcy is directly correlated with aortic stiffness, decreased renal 
function, endothelial dysfunction, and hypertension, with increases in 
homocysteine eliciting linear increases in the aforementioned pathologies, 
suggesting a causative effect (Bortolotto et al., 1999; Naess et al., 2013; Sutton-
Tyrrell et al., 1997; Wiernicki et al., 2011; Zheng et al., 2013).   
 Hyperhomocysteinemia occurs when there is impairment in one or more of 
the metabolic processes used to remove homocysteine from the body. CBS or 
MTHFR mutations, low dietary folate, impaired renal clearance, or a high dietary 
intake of methionine are known causes of HHcy (Hayden & Tyagi, 2004; Kanwar 
et al., 1976; S. C. Tyagi et al., 2005; Veeranki  & Tyagi, 2013). Several of the 
mechanisms through which HHcy may cause disease have been discovered. 
Hcy increases reactive oxygen species (ROS) production through the formation 
of mixed disulfides, protein homocysteinylation, and through auto-oxidation 
(Signorello et al., 2007; S. C. Tyagi et al., 2005).  Homocysteine has been shown 
to cause dephosphorylation and uncoupling of endothelial nitric oxide synthase 
(eNOS), leading to a decrease in endothelial NO production (Tyagi et al., 2009).  
Decreased nitric oxide attenuates vascular responsiveness to wall shear caused 
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by changes in blood flow, preventing proper vaso-relaxation.  Moreover, the 
increased wall stress associated with less pliable vessels elevates arterial 
pressures and decreases perfusion to the surrounding and distal tissues 
(Jacobson et al., 2007; Levy et al., 2008). This reduction in perfusion increases 
ROS production, starting a vicious cycle of ROS accumulation and tissue 
damage.   
Signorello et al. demonstrated that type 2 diabetics have increased total 
plasma homocysteine levels when compared to control subjects (Signorello et 
al., 2007). It was found that the platelets of type 2 diabetic patients had 
significantly lower basal NO levels, decreased levels of reduced glutathione (an 
intracellular anti-oxidant), and increased ROS production when compared to 
those of control subjects.  Hcy has also been shown to inactivate peroxisome 
proliferator activated receptor – α and – γ  (PPAR-α, PPAR-γ), which are pro-
antioxidants that have been shown to promote synthesis of superoxide 
dismutase (SOD) and decrease oxidative stress (Mujumdar, Tummalapalli, Aru, 
& Tyagi, 2002). This decreased activity of PPAR by Hcy may escalate 
constrictive vascular remodeling.   
 
Hyperhomocysteinemia and Skeletal Muscle 
 Although common muscular disorders, such as muscular dystrophy, 
sarcopenia and immobilization, have been extensively researched, there is a not 
a lot of data available on the effects of HHcy on skeletal muscle function.  Swart 
et al. demonstrated that in elderly individuals (mean = 75.6 years of age), plasma 
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Hcy levels had a strong inverse correlation with grip strength and functional 
capabilities. High Hcy levels resulted in poor grip strength in men and lower 
functional ability, with functional abilities including walking, climbing stairs and 
rising from a chair (Swart et al., 2013).  In cystathione beta synthase deficient 
mice (CBS+/-), a model for mild to moderate HHcy, It was demonstrated that 28 
days after induction of hind limb ischemia CBS+/- mice displayed blunted hind 
limb perfusion and lower collateral blood vessel development when compared to 
WT mice (Veeranki, Givvimani, Pushpakumar, & Tyagi, 2014). CBS+/- mice also 
demonstrated blunted vascular endothelial growth factor (VEGF), hypoxia 
inducible factor (HIF1-α) and peroxisome proliferator activated receptor 
coactivator 1-α (PGC1-α) after 28 days of ischemic recovery, when compared to 
control. Another study by Veeranki et al. demonstrates that CBS+/- skeletal 
muscle is less fatigue resistant, produces less contractile force and has lower 
muscle ATP levels compared to C57 wild type mice (S. Veeranki et al., 2015). It 
was discovered that CBS+/- skeletal muscle has lower dystrophin and 
mitochondrial transcription factor A (mtTFA) when compared to controls (See 
Figures 2 and 3 below). Although these studies demonstrate some of the effects 
of HHcy on skeletal muscle, more data is needed to determine the mechanism by 
which HHcy causes skeletal muscle impairment.  
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Figure  2: Maximal force production is decreased in the soleus and EDL of 
CBS +/- mice, possibly due to decreased skeletal muscle ATP generation.  
The above data are reproduced from a 2015 article by Veeranki et al., (S. 
Veeranki et al., 2015).  The above data demonstrate that maximal force 
generation is reduced in the A)EDL and B)soleus of CBS +/- mice. This is likely 
due to an observed decrease in C) skeletal muscle ATP production. 
 
A 
C 
B 
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Figure  3: CBS+/- mice have lower skeletal muscle expression of 
Dystrophin, mtTFA and NRF-1; this is reversed with exercise.  The above 
data are reproduced from a 2015 article by Veeranki et al.,(S. Veeranki et al., 
2015).  These data indicate that A) dystrophin, mtTFA  and B) nuclear respiratory 
factor (NRF-1), a transcriptional regulator of mtTFA, are significantly reduced in 
CBS +/- mice compared to C57. Exercise increases mtTFA and NRF-1 levels.  
A 
B 
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Matrix Metalloproteinase-9 
Matrix Metalloproteinases (MMP’s) are largely responsible for the proper 
degradation of the ECM in healthy individuals. MMP’s are zinc and calcium 
dependent endoproteinases that are secreted by many cell types such as 
macrophages, fibroblasts, vascular smooth muscle cells and myocytes.  Matrix 
Metalloproteinase-9 (MMP-9) is classified as a gelatinase that has the ability to 
degrade components of the extracellular matrix (ECM), including collagen type IV 
and elastin (the main elastic component of the arterial wall).  MMP-9 is stimulated 
through activation of extracellular matrix metalloproteinase inducer (EMMPRIN) 
via p38 MAPK stimulation (Huang et al., 2011; Reddy et al., 2010), as well as 
through extracellular signal-regulated kinase (ERK)/ nuclear factor-κB (NF-κB) 
dependent activator protein (AP-1) activation (Fan, Meng, Wang, Cao, & Wang, 
2011; Seung Jin Lee et al., 2012; Moshal et al., 2006; Reddy et al., 2010; Neetu 
Tyagi et al., 2009).  In healthy muscle tissues, MMP-9 is known for playing a role 
in the repair and remodeling of the tissue as well as angiogenesis (Bellafiore et 
al., 2013; Chen & Li, 2009; Kherif et al., 1999; Lewis, Tippett, Sinanan, Morgan, 
& Hunt, 2000; Mackey, Donnelly, Turpeenniemi-Hujanen, & Roper, 2004; 
Zimowska, Brzoska, Swierczynska, Streminska, & Moraczewski, 2008).  It has 
been localized to cardiomyocytes, around skeletal muscle fibers, capillaries and 
within the skeletal muscle ECM (Bellafiore et al., 2013; Rullman et al., 2009).  
Research has demonstrated that MMP-9 is crucial for the onset of angiogenesis 
(Bellafiore et al., 2013) and for maintaining proper compliance and distensibility 
of arteries (Flamant et al., 2007). During growth and repair of skeletal muscle, 
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MMP-9 has been shown to stimulate satellite cell migration and differentiation 
through degradation of the ECM basement membrane, assisting with their 
mobility into the muscle (Chen & Li, 2009; Kherif et al., 1999; Lewis et al., 2000; 
Zimowska et al., 2008).    
 
MMP-9 and Disease 
Excessive inflammation and oxidative stress can lead to abnormal 
activation of MMP-9, causing excessive degradation of the ECM, abnormal 
vascular remodeling and endothelial dysfunction, which are associated with 
hypertension and arterial stiffness (Onal et al., 2009; Wallace et al., 2005). 
Wallace et al. demonstrate that patients with isolated systolic hypertension had 
significantly elevated MMP-9 levels and higher pulse wave velocities (PWV, a 
measure of arterial stiffness) when compared to age-matched controls (Wallace 
et al., 2005). It was determined that MMP-9 levels correlated linearly with PWV, 
suggesting that MMP-9 may be, at least in part, a cause of arterial stiffening and 
hypertension.  
Tyagi et al. demonstrate that mitochondrial induced oxidative stress 
activation of MMP-9 leads to degradation of the gap junction protein connexin-43 
(Cx-43) in the myocardium (N. Tyagi, Vacek, Givvimani, Sen, & Tyagi, 2010). 
Degradation of Cx-43 elicits fibrosis and ventricular dysfunction.  Another study 
by Onal et al. confirms the finding that MMP-9 levels are higher in individuals with 
hypertension and that antihypertensive treatment lowers MMP-9 to control group 
levels (Onal et al., 2009).  Furthermore, MMP-9 is induced by EMMPRIN in the 
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atherosclerotic carotid lesion of advanced atherosclerotic plaque, leading to 
abnormal ECM remodeling and atheroma instability (Yoon et al., 2005).  
 
MMP-9 and Skeletal Muscle 
 Although there has been extensive research on the effects of MMP-9 in 
cardiovascular disease and vascular remodeling, the data on the effects of 
abnormal MMP-9 expression in skeletal muscle diseases is relatively limited. 
With MMP-9 playing a large role in collagen/elastin degradation in the ECM of 
skeletal muscle tissues, it would suggest that MMP-9 hyperactivity could create 
pathological conditions. In Duchenne’s muscular dystrophy (DMD), which is 
characterized by skeletal muscle weakness and atrophy, it was determined that 
MMP-9 levels are significantly elevated in serum samples of mdx mice and DMD 
patients when compared to their healthy counterparts (Nadarajah et al., 2011).  
Similarly, people and animals infected with immunodeficiency viruses suffer from 
exacerbated muscle wasting. In rhesus macaques infected with the simian 
immunodeficiency virus, chronic binge alcohol administration leads to significant 
increases in MMP-9 mRNA expression in skeletal muscle and was associated 
with ECM remodeling and fibrosis (Dodd et al., 2014).   
 
MMP-9 and Hyperhomocysteinemia 
 Hyperhomocysteinemia is a well-known stimulus for MMP-9 activity (Lee 
et al., 2012; Moshal et al., 2006; Tyagi et al., 2009) and strongly correlates with 
its activity in vascular disease (Wiernicki et al., 2011). Hcy stimulates MMP-9 
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production in several cell types including ventricular endothelial cells, brain 
endothelial cells and macrophages. Studies suggest that Hcy largely upregulates 
MMP-9 expression in these cell lines through an oxidative stress induced 
ERK/AP-1 pathway (Lee et al., 2012; Moshal et al., 2006; Tyagi et al., 2009). 
Tyagi et al. determined that HHcy also induces MMP-9 activation through ERK, 
leading to degradation of the extracellular matrix (Tyagi et al., 2009). It was 
shown that homocysteine acts as an antagonist of the gamma aminobutyric acid 
–A (GABA-A) receptor, leading to increased ROS production, increased MMP-9 
activity, and decreased NO production through the uncoupling of eNOS. 
Pharmacological stimulation of the GABA-A receptor attenuates Hcy induction of 
MMP-9. The GABA-A receptor controls several antioxidative enzymes, such as 
thioredoxin and NADPH oxidase-4, indicating enhanced ROS production acts as 
the MMP-9 stimulus. Lee et al. determined that Hcy induction of MMP-9 also 
occurs through a separate Akt pathway in murine macrophages (Seung Jin Lee 
et al., 2012). 
 
EMMPRIN induction of MMP-9 
Extracellular matrix metalloproteinase inducer, or EMMPRIN, is a 
membrane bound protein found in most cell types. It is known for mediating 
cellular signaling cascades, particularly those stimulating MMP’s (Venkatesan et 
al., 2010).  Elevated EMMPRIN expression is associated with ROS production 
(Siwik et al., 2008) and numerous disease states such as atherosclerosis (Major, 
Liang, Lu, Rosebury, & Bocan, 2002), rheumatoid arthritis (Zhu et al., 2005) and 
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cancer (Guo, Li, Zucker, & Toole, 2000).   Extensive research has demonstrated 
that EMMPRIN is a potent inducer of MMP-9 (Fan et al., 2011; Reddy et al., 
2010; Tarin et al., 2011; Yoon et al., 2005).  Studies suggest that EMMPRIN is 
stimulated by several inflammatory molecules including the inflammatory 
cytokines such as interleukin-18 and visfatin as well as cyclophilin A, a potent 
ROS inducer (Fan et al., 2011; Reddy et al., 2010; Yuan, Ge, & He, 2010). The 
exact pathways for EMMPRIN stimulation are still largely undetermined, 
however, it appears that these molecules stimulate EMMPRIN through a cGMP, 
p38-ERK 1/2-NF-κB signaling pathway (Fan et al., 2011; Huang et al., 2011; 
Tarin et al., 2011). Interestingly, it appears that EMMPRIN utilizes the same 
p38/ERK/NF-κB pathway to stimulate other molecules such as MMP-9 (Reddy et 
al., 2010; Yuan et al., 2010). EMMPRIN and MMP-9 co-expression are found 
prevalently in atherosclerotic plaques/atheromas and ischemia/reperfusion injury 
to cardiac tissue (Major et al., 2002; Tarin et al., 2011; Yoon et al., 2005). 
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Macrophages 
 Macrophages are mononuclear white blood cells that are derived from 
differentiating monocytes in tissues. They are used both in adaptive and innate 
immune responses and are phagocytic by nature, meaning they engulf debris 
and pathogens for disposal. Macrophages stimulate the immune system by 
signaling other immune cells such as lymphocytes and promote inflammation 
through the release of pro-inflammatory cytokines, ROS and NO, which are used 
as an attack mechanism against invading pathogens. After phagocytosis of 
pathogen, macrophages present the antigen to a corresponding helper T cell, 
which then signals for the production of antibodies against the antigen, helping 
with the body’s adaptive immunity.  Although macrophages are necessary for 
adequate immune response, they have been suggested to exacerbate a number 
of diseases such as obesity, type II diabetes, atherosclerosis, and cancer (Mills, 
2012; Sica & Bronte, 2007; Sica & Mantovani, 2012; Tavakoli & Asmis, 2012).  
 
M1 vs M2 Macrophages 
The phenotype and function of macrophages is controlled by 
environmental signals. Two polarized phenotypes of macrophages are denoted 
as M1 or M2.  The M1 phenotype is the destructive, “classically activated” 
subset, while the M2 is called the “alternatively activated” subset, associated with 
growth and repair (Mills, 2012; Sica & Mantovani, 2012).  The M1 phenotype is 
stimulated by Interleukin-12 (IL-12), lipopolysaccharide and interferon-γ and can 
be identified by high expression of the cell surface marker CD40 (Aron-
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Wisnewsky et al., 2009; Munder, Mallo, Eichmann, & Modolell, 1998; Sica & 
Mantovani, 2012). M2 macrophages are known to be stimulated by interleukin-10 
(IL-10) and interleukin-4 (IL-4) and can be identified by the cell surface markers 
CD163 and CD206 (Aron-Wisnewsky et al., 2009; Fiorentino, Zlotnik, Mosmann, 
Howard, & O'Garra, 1991; Lang, Patel, Morris, Rutschman, & Murray, 2002; Sica 
& Mantovani, 2012).  
Macrophages are recruited to a specific area through chemical signaling 
known as chemotaxis.  When the resulting phenotype of the signaled 
macrophage is M1, the macrophage attacks pathogens with a barrage of pro-
inflammatory factors. The M1 macrophages will release pro-inflammatory 
cytokines, ROS, and NO through increased production of inducible nitric oxide 
synthase (iNOS) (Leibovich et al., 1987; Mills, 2012; Sica & Mantovani, 2012; 
Weisser, McLarren, Kuroda, & Sly, 2013). When signaled to damaged 
endothelium or areas of arterial damage, the pro-inflammatory action elicited by 
M1 macrophages is thought to initiate or progress the damage that causes 
vascular pathologies such as atherosclerosis.  
Conversely, the M2 phenotype is known to help promote survival and 
angiogenesis through the release of anti-inflammatory cytokines and growth 
factors. M2 macrophages have been shown to release IL-10, an inhibitor of pro-
inflammatory cytokines, PPAR-γ, which is a pro-antioxidant that improves insulin 
sensitivity, and VEGF, which is associated with angiogenesis, as well as other 
proliferative factors (Fiorentino et al., 1991; Lang et al., 2002; Mills, 2012; 
Odegaard et al., 2007; Sica & Mantovani, 2012; Zeyda et al., 2007).  
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M1 and M2 Macrophages in Injury and Disease 
Kigerl et al. were able to demonstrate the difference between the M1 and 
M2 phenotype in an injured mouse spinal cord (Kigerl et al., 2009). Their data 
suggest that M1 macrophages rapidly respond at sites of spinal cord damage 
and produce a neurotoxic effect, which profoundly overpowers the M2 response. 
In contrast, it is shown that induction of the M2 phenotype in these macrophages 
actually elicits axonal growth for neural regeneration.   
Obesity displays a low level of chronic inflammation that is thought to be 
associated with the development of associated diseases, such as insulin 
resistance. Aron-Wisnewsky et al. demonstrate that M1 macrophages are 
significantly increased in the adipose tissue of obese women (Aron-Wisnewsky et 
al., 2009). After 3 months of gastric bypass surgery, it was found that the ratio of 
M1/M2 macrophages was 2-fold lower than pre-surgery, suggesting a switch to a 
less inflammatory profile.  
El Hadri et al. found that when stimulated with thioredoxin-1, an anti-
inflammatory protein, macrophages are shifted to an M2 phenotype and this 
switch antagonizes atherosclerosis (El Hadri et al., 2012). In contrast, despite the 
proliferative, anti-inflammatory nature of M2 macrophages, it has been 
discovered that M2 macrophages may also be associated with increased 
atherogenesis. Oh et al. demonstrated that M2 macrophages are responsible for 
foam cell formation and deposition into the intima of the vascular wall, promoting 
arterial plaque formation (Oh et al., 2012).  IL-4 and IL-10 stimulation of 
macrophages promoted ER stress that generated PPAR-γ and JNK activation, 
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leading to an M2 phenotype. When the M2 macrophages were exposed to 
oxidized low density lipoprotein, foam cell formation occurred because of CD36 
and scavenger receptor-A1 (SR-A1) induction. This transformation of M2 
macrophages into foam cells could play a major role in the formation and 
progression of atherosclerotic plaque.  
 
Macrophages and Hyperhomocysteinemia 
Interestingly, homocysteine shares a causative link with the atherogenic 
actions of M1 and M2 macrophages. Research suggests that that HHcy induces 
VEGF and monocyte chemoattractant protein-1 (MCP-1, a potent chemotactic 
agent), expression via an NF-κB dependent pathway in THP-1 human 
macrophages, which are both associated with vascular disease progression 
(Wang et al., 2001). This study demonstrates HHcy stimulates macrophage 
migration into the arterial intima through a 4.8 fold induction of MCP-1.  Other 
studies also demonstrate that Hcy upregulates VEGF production in macrophages 
via NF-κB activation (Kiriakidis et al., 2003; Maeda, Yamamoto, Fujio, & Azuma, 
2003). More recently, a study by Lee et al. suggested that Hcy treatment resulted 
in elevated MMP-9 production in the J774A.1 murine macrophage cell line (Lee 
et al., 2012). 12 hours of 300µM Hcy treatment resulted in significantly elevated 
MMP-9 protein expression and activity. Further analysis revealed that this 
induction occurred through ERK and Akt pathways.  
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Macrophages in Skeletal Muscle 
Macrophages are typically present in substantial quantity in the skeletal 
muscle, largely in the epimysium and perimysium (Chazaud et al., 2009). One 
major role of macrophages in the skeletal muscle is to assist with tissue growth 
and repair.  Damaged muscle fibers attract monocytes to the site of injury 
through chemotaxis, where the monocytes differentiate into macrophages. Upon 
phagocytosis of muscle cell debris, macrophages shift towards an anti-
inflammatory profile, which causes them to release growth factors such as TGF-β 
and basic fibroblast growth factor (bFGF), resulting in stimulation of muscle 
satellite cell migration (Arnold et al., 2007; Robertson et al., 1993). The 
macrophage shift towards an anti-inflammatory or M2 profile seems to occur 
between 1 to 3 days post injury (Chazaud et al., 2009). Tissue injury causes 
significant increases in macrophage infiltration 2 days post injury and a 
substantially greater increase after 3 days. However, these levels begin to 
subside by day 6 (Pimorady‐Esfahani et al., 1997).   
Research suggests that macrophages are rather crucial for skeletal 
muscle growth and repair. If monocyte recruitment to the site of damaged 
skeletal muscle is interrupted within the first 24 hours post-injury, the repair 
process is completely attenuated. Inflammatory macrophages stimulate 
myogenic cell proliferation, while anti-inflammatory macrophages stimulate 
myogenic cell differentiation into myotubes (Arnold et al., 2007). Complete 
removal of macrophages after muscular injury also hinders the repair process 
29 
 
and decreases the diameter of regenerating muscle fibers (Arnold et al., 2007; 
Chazaud et al., 2009).  
As discussed earlier, during pathological conditions, macrophage 
infiltration into the skeletal muscle can be heavily increased and promote a 
potent inflammatory profile. This chronic state of inflammation elicits adverse 
muscle remodeling through tissue fibrosis and muscular atrophy.  
 
 
Exercise Training 
It has been well established that regular exercise is associated with 
improvements in overall physical fitness, maintenance of health, a decreased risk 
of many disease states, and more recently, alleviation of many disease 
pathologies (Fiuza-Luces, Garatachea, Berger, & Lucia, 2013). Despite this 
common knowledge, technological advancements associated with modern day 
living have caused dramatic increases in sedentary lifestyle.  Approximately 43% 
of American adults and 31% of adults worldwide are considered to be physically 
inactive (Hallal et al., 2012).  This lack of physical exercise has been associated 
with elevated cardiovascular disease mortality risk and is estimated to be 
attributable for 16% of all-cause death (Blair, 2009). Furthermore, decreased 
physical activity has also been associated with the development of hypertension 
and obesity (Tremblay, Esliger, Copeland, Barnes, & Bassett, 2008), which are 
known to cause a wide variety of other disease states.   
30 
 
Supporting the health promoting advantages of regular exercise, a review 
by Fiuza-Luces et al. suggests that regular exercise has physiological health 
benefits that are equivalent to a multi-drug (blood thinner, anti-diabetic, anti-
hypertensive, anti-lipid/cholesterolemic) regimen (Fiuza-Luces et al., 2013). 
When compared to the benefits of this multiple drug treatment program, exercise 
is as capable, if not more proficient, at improving lipid profile, blood pressure, 
diabetes prevention, and reduction of cardiovascular events.  Most of these 
benefits are derived from chemicals released by contracting skeletal muscle 
(myokines), such as IL-6, which increases the production of anti-inflammatory 
cytokines, angiogenic factors, and follistatin, which improves muscle growth and 
possibly insulin sensitivity through inhibition of myostatin (Pedersen, Akerstrom, 
Nielsen, & Fischer, 2007).   
Acute exercise has been shown to elevate NO production through a 37% 
increase in nitric oxide synthase (NOS) in rat gastrocnemius muscle (Roberts, 
Barnard, Jasman, & Balon, 1999).  Through adaptation, regular exercise 
improves endothelial function, at least in part, due to elevated endothelial nitric 
oxide synthase (eNOS) mRNA expression, allowing for enhanced NO production 
and vasoreactivity (Fogarty et al., 2004; Griffin, Woodman, Price, Laughlin, & 
Parker, 2001; Hambrecht et al., 2000). Improved stem cell production and 
release also contributes to the benefits derived from exercise (Macaluso & 
Myburgh, 2012). Endothelial progenitor cells stimulated by exercise have been 
shown to migrate to the damaged endothelium to initiate repair or angiogenesis, 
improving vascular function (Crosby et al., 2000; Moreno, Sanz, & Fuster, 2009).  
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It has also been revealed that exercise improves cellular responsiveness to 
stress through improved metabolic efficiency and elevated anti-oxidative 
capacity, resulting in decreased free radicals and mitigation of ROS induced 
pathologies (Gomez-Cabrera et al., 2005; Jackson, 2005; Khassaf et al., 2001; 
McArdle, Pattwell, Vasilaki, Griffiths, & Jackson, 2001; Radak, Chung, & Goto, 
2008).  
 
Exercise and Homocysteine 
It has been demonstrated that exercise is capable of lowering Hcy levels, 
suggesting that exercise can potentially negate the adverse effects of HHcy on 
different organs (Hrncic et al., 2013; König et al., 2003; Neuman et al., 2013; 
Randeva et al., 2002; Vincent et al., 2006). Neuman et al. stated that exercise 
was capable of preventing increases in plasma Hcy concentration that were 
produced by 7 weeks of a folate restricted diet in mouse models (Neuman et al., 
2013). The low folate diet group that was not exercised displayed significant 
increases in Hcy levels when compared to non-exercise controls and controls 
receiving exercise. It was demonstrated that this prevention of 
hyperhomocysteinemia was associated with a 2 fold increase in renal betaine-
homocysteine S-methyltransferase (BHMT) activity. BHMT is a folate 
independent methyltransferase that remethylates Hcy into methionine by utilizing 
a methyl group from betaine.  Another study revealed the ability of exercise to 
prevent increases in lipid peroxidation and decreases in superoxide dismutase 
and catalase activity by Hcy in mice (Hrncic et al., 2013). Human studies have 
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also discovered that exercise lowers Hcy levels in overweight and obese adults 
as well as in women with polycystic ovarian syndrome (Randeva et al., 2002; 
Vincent et al., 2006).  
 
Exercise and MMP-9 
Despite an abundance of research on MMP-9 and its association with 
vascular complications, the effects of regular exercise on MMP-9 are rather 
unclear.  After single acute bouts of exercise, it is shown that MMP-9 activity is 
elevated around the capillaries and cardiomyocytes (Bellafiore et al., 2013; 
Rullman et al., 2009). Increased serum levels of MMP-9 have been reported after 
8 days of a single exercise bout and MMP-9 remains elevated even after 15 days 
of training (Bellafiore et al., 2013; Mackey et al., 2004; Rullman et al., 2009). This 
could suggest that MMP-9 is being utilized to help promote exercise induced 
angiogenesis. Interestingly, although MMP-9 activity is increased after a single 
exercise bout, it has been revealed that there is no change in enzyme activity 
after extended training regimens, therefore, it is possible that MMP-9 activity may 
only be utilized in the initial phases of new capillary growth (Rullman et al., 2009). 
 
Exercise and Macrophages 
It is known that acute bouts of exercise stimulate the phagocytic activity of 
macrophages (De la Fuente, Martin, & Ortega, 1990; Ferrandez & De la Fuente, 
1999). This makes sense since macrophages play a crucial role in phagocytosis 
of muscle debris and the muscular repair process. Regular exercise appears to 
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increase phagocytic activity of macrophages as well, which is more exaggerated 
in the elderly, whom typically have a blunted macrophage response to pathogens 
(Ferrandez & De la Fuente, 1999).  This could be an important mechanism 
through which exercise improves immune responsiveness.  Although the effect of 
exercise on macrophage activity has been well researched, there seems to be 
little information available regarding the effects of regular exercise on M1 vs M2 
macrophage phenotype differentiation. One study suggests that mice being fed a 
high fat diet display a greater ratio of adipose tissue M1/M2 macrophages 
compared to normal diet controls (Kawanishi, Yano, Yokogawa, & Suzuki, 2010). 
After 16 weeks of exercise training, not only was the increased ratio of M1/M2 
macrophages attenuated in the high fat diet group, but the expression level of M2 
macrophages was markedly increased. This was accompanied by a decrease in 
inflammatory cytokines. Since this is the only study involving exercise and M1/M2 
macrophages, it is clear that more research is needed regarding M1 vs M2 
macrophage modification by exercise.  
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CHAPTER III 
HYPOTHESIS AND SPECIFIC AIMS 
 
Key Objective 
 The objective of this study was to determine the effects of 
hyperhomocysteinemia on skeletal muscle dysfunction and investigate if exercise 
can attenuate these effects.  
 
Hypothesis 
 Hyperhomocysteinemia promotes adverse remodeling of skeletal muscle 
through induction of inflammatory mechanisms and exercise will mitigate this 
inflammatory state (See Figure 4).  
 
Specific Aims 
Specific Aim 1: To investigate if HHcy impairs skeletal muscle perfusion and 
function and determine if exercise mitigates this effect. 
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Specific Aim 2:  To investigate changes to the inflammatory state of the skeletal 
muscle due to HHcy and determine if exercise can reverse this effect.  
Specific aims 1 and 2 will be discussed in Chapter IV. 
 
Specific Aim 3: To investigate changes in macrophage phenotype and skeletal 
muscle infiltration due to HHcy and determine if exercise can mitigate this effect.  
Specific aim 3 will be discussed in Chapter V.  
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Figure 4: Schematic Representation of Overall Hypothesis 
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CHAPTER IV 
SKELETAL MUSCLE DYSFUNCTION DUE TO HYPERHOMOCYSTEINEMIA 
 
Introduction 
 Hyperhomocysteinemia (HHcy), having plasma homocysteine levels 
>15µM, is a significant risk factor associated with hypertension, atherosclerosis, 
abdominal aortic aneurysms and diabetes (Bortolotto et al., 1999; Signorello et 
al., 2007; Sutton-Tyrrell et al., 1997; Wiernicki et al., 2011; Zheng et al., 2013). 
HHcy can develop due to high dietary methionine, insufficient dietary folate, or 
genetic defects in enzymes that metabolize homocysteine, such as cystathione 
beta synthase or methyl-tetrahydrofolate reductase.  People and animals with 
HHcy display pathological imflammation and remodeling of their cardiac and 
vascular smooth muscle (Bortolotto et al., 1999; Mujumdar et al., 2002; Shai et 
al., 2004; Signorello et al., 2007; Zheng et al., 2013). Muscular remodeling 
involves degradation and regeneration of fibrous extracellular matrix (ECM) 
proteins such as collagen, elastin and fibronectin.  Pathological remodeling can 
occur during states of chronic inflammation and is characterized by excessive 
collagen deposition and depletion of elastin, causing the muscle to become 
fibrotic, unstable and rigid (Gillies and Lieber, 2011).  
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 Homocysteine is known to induce several inflammatory factors such as 
reactive oxygen species (ROS), matrix metalloproteinase-9 and stimulation of 
macrophage migration through chemotaxis (Lee et al., 2012; Tyagi et al., 2009; 
Wang et al., 2001).  MMP-9 is an endoproteinase that degrades collagen within 
the ECM.  Its ability to degrade the extracellular matrix has been implicated in 
cardiovascular remodeling (Spinale et al., 2000;  Tyagi et al., 2010). It is strongly 
associated with heart failure, hypertension and arterial stiffness and positively 
correlates with Hcy levels (Onal et al., 2009; Spinale et al., 2000; Wiernicki et al., 
2011; Yasmin et al., 2005). Macrophages are required for the growth and repair 
of damaged muscle tissue, but chronic inflammation can cause macrophages to 
become hyperactive and destructive, leading to fibrosis of tissue. Hcy has been 
shown to stimulate macrophage migration, indicating that HHcy could promote 
remodeling through macrophage activation as well (Wang et al., 2001).   
 Limb immobilization, diabetes and muscular dystrophy all display 
pathological remodeling through excessive fibrosis of the skeletal muscle 
(Alexakis et al., 2007; Berria et al., 2006; Duance et al., 1980; Williams & 
Goldspink, 1984). Macrophages and MMP-9 are both present in the skeletal 
muscle for normal growth and repair, but the inflammation induced by HHcy may 
cause adverse skeletal muscle remodeling through amelioration of their activity.  
Skeletal muscle is a very metabolically active tissue and therefore requires a rich 
blood supply for proper perfusion and function (Holloszy & Coyle, 1984; Saltin, 
Radegran, Koskolou, & Roach, 1998).  A lack of perfusion reduces clearance of 
metabolic oxidative byproducts, which would lead to inflammation.  With HHcy 
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impairing blood flow through vascular dysfunction, it is very plausible that HHcy 
could promote or exacerbate pathological remodeling of skeletal muscle as well.   
 Individuals with HHcy produce lower maximal grip strength and impaired 
functional capabilities when compared to healthy counterparts (Swart et al., 
2013). In CBS+/- mice, a model for HHcy, it is demonstrated that HHcy impairs 
hindlimb reperfusion angiogenesis after ischemia caused by femoral artery 
ligation (Veeranki et al., 2014).  Another study from Veeranki et al. demonstrates 
that the skeletal muscle of CBS+/- mice is more fatigable and produces less 
contractile force than wild type mice. It was determined that the skeletal muscle 
has blunted ATP production, which may be the cause of the fatigability (Veeranki 
et al., 2015).  The CBS+/- muscle also has decreased dystrophin and 
mitochondria transcription factor A (mtTFA) protein expression compared to wild 
type, indicating that the muscle is less functional and has lower mitochondrial 
activity. There was also an accompanied increase in mir-31 and mir-494, which 
respectively inhibit dystrophin and mtTFA.  Additionally, there was a significant 
decrease in nuclear respiratory factor-1 (NRF-1) expression, which is a 
transcriptional promoter of mtTFA. A 4 week swimming protocol was 
administered to see if these effects could be attenuated. With the exception of 
dystrophin, all of the molecular changes observed in CBS+/- were reversed with 
exercise. With HHcy clearly causing functional and molecular changes to skeletal 
muscle, we decided to further investigate what changes HHcy is inducing in the 
skeletal muscle tissue. It is our hypothesis that HHcy impairs perfusion and 
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promotes pathological remodeling in skeletal muscle by inducing chronic 
inflammation. We believe that exercise will mitigate these effects.   
 
Methods 
Animals and Animal Care 
C57BL/6J (WT), CBS+/-(B6129P2), FVB (FVB/NJ) and  MMP-9-/- 
(FVB.Cg-Mmp9tm1Tvu/J) were obtained from Jackson Laboratories. CBS+/- mice 
are heterozygous knockout mice that display HHcy and are based on the C57 
WT model. MMP-9 -/- mice are based on the FVB (WT) model and are 
homozygous knockouts for MMP-9.  CBS/MMP-9 double KO mice were bred in 
our animal facilities through mating of MMP-9-/- and CBS+/- mice.  Only 
CBS/MMP-9 mice that were genotyped as being heterozygous knockouts for 
CBS and MMP-9 homozygous knockouts were used for this study. Animals were 
kept in our laboratories animal facility which exposes them to 12 hour of light and 
12 hours of dark daily. They were fed normal chow and had free access to a 
fresh water supply.  For the purpose of harvesting tissues, animals were fully 
anesthetized using tri-bromoethanol and euthanized via exsanguination. These 
methodologies are both considered humane and appropriate procedures by the 
University’s IACUC. Gastrocnemius muscles were harvested for analysis and 
snap frozen in liquid nitrogen for western blotting and PCR analysis or 
cryopreserved in Peel-A-Way disposable tissue molds (Polysciences, 
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Warrington, PA) containing tissue freezing medium (Triangle Biomedical 
Sciences; Durham, NC) by freezing in liquid nitrogen for cryo-sectioning.  
 
Exercise Protocol 
All 5 mouse breeds had a control group that received no exercise training 
for 6 weeks and a group that was exercised on a 6 lane treadmill (Columbus 
Instruments; Columbus, OH) for 6 weeks. The treadmill protocol was personally 
designed while following mouse exercise guidelines as outlined in the “Resource 
Book for the Design of Animal Exercise Protocols,” which was published by the 
American Physiological Society in February of 2006 (Kregel et al., 2006).  Prior to 
the start of exercise, mice were placed in the lanes of the treadmill daily for 5 
days for 20 minutes per day with no belt movement to allow them to acclimate to 
the environment.  Mice were exercised 5 days per week for 6 weeks with 
increasing intensity each day. The first two weeks were low intensity to allow for 
proper acclimation to a moving belt on the treadmill. The protocol consisted of a 
standard training phase for 20 minutes followed by a high-intensity sprint phase 
to induce muscular hypertrophy.  Before the start of the study, it was determined 
that most mouse models had a very difficult time running at speeds greater than 
20 m/min for more than a very short duration. To ensure that the protocol finished 
at a high intensity, a final training speed of 17 m/min (85% max speed at 
baseline) with a final sprint phase speed of 20 m/min (100% of max speed at 
baseline) were utilized.  On the first day of exercise training, the mice began the 
training phase at 5 m/min for 20 minutes (or 100 m in 20 min) and a 15 m/min 
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sprint speed for 10 meters. The training phase increased by 0.5 m/min every day 
for the duration of the protocol until it reached 17 m/min for 20 minutes (or 340 
meters in 20 min) during the final week, where the speed was held constant for 
the final 5 training sessions. The sprint phase distance at 15 m/min increased by 
5 meters every training session until the half way point where a combination of 
15 m/min and 20 m/min training speeds were utilized for 11 training sessions, 
followed by 10 training sessions at 20 m/min for increased distance. See figure 5 
and table 1 below for clarification.   
 
Figure 5.  Line graph representation of the exercise protocol. Red indicates 
the distance run in 20 minutes for the standard training part of the protocol. 
Green represents the distance run at 15 m/min for the sprint phase, while blue 
represents the distance run at 20 m/min.  
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 Table 1.  Table layout of the exercise protocol.  
 
 
 
  
Day of Speed For 20 Distance at Distance at
Training Mins (m/min) 15 m/min 20 m/min
1 5 10 0
2 5.5 15 0
3 6 20 0
4 6.5 25 0
5 7 30 0
6 7.5 35 0
7 8 40 0
8 8.5 45 0
9 9 50 0
10 9.5 50 5
11 10 50 10
12 10.5 50 15
13 11 50 20
14 11.5 50 25
15 12 50 30
16 12.5 50 35
17 13 50 40
18 13.5 50 45
19 14 50 50
20 14.5 50 50
21 15 0 80
22 15.5 0 85
23 16 0 90
24 16.5 0 95
25 17 0 100
26 17 0 100
27 17 0 100
28 17 0 100
29 17 0 100
30 17 0 100
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Blood Pressure Measurments 
Blood pressure data was collected before the start of exercise (or control) 
and again two days following the completion of exercise training (or 6 weeks of 
control).  Measurements were taken using a common, non-invasive tail cuff 
system (CODA; Kent Scientific: Torrington, CT). Animals were physically 
restrained using polymer harnesses designed for use with this system. The 
animals were placed on a warming platform for 10 minutes at 37°C to allow them 
to acclimate. Mean blood pressure measurements were recorded and used for 
this study.  
 
Antibodies and reagents 
Antibodies for homocysteine, myostatin and MMP-9 were purchased from 
Abcam (Cambridge, MA), while antibodies for VEGF, IL-1β, PPAR-γ, EMMPRIN, 
iNOS and all secondary antibodies were purchased from Santa Cruz 
Biotechnologies (Santa Cruz, CA).  The (glyceraldehyde 3-phosphate 
dehydrogenase) GAPDH antibody was purchased from EMD Millipore (Billerica, 
MA). All PCR primers were purchased from Invitrogen (Carlsbad, CA).   
 
Plasma Homocysteine Measurement 
To measure the differences in levels of homocysteine and 
homocysteinylated proteins between groups, blood samples were collected 
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through the vena cava of anesthetized animals. Sodium citrate was used to coat 
the interior of the syringe prior to blood collection to prevent coagulation. Blood 
samples were centrifuged at 6000Xg for 10 minutes and plasma (supernatant) 
was carefully pipetted into another tube. Plasma samples were stored at -80°C 
until needed.  A dot blot was utilized to measure differences in plasma Hcy 
levels. Equal volumes of plasma from each sample were blotted onto a 
nitrocellulose membrane and allowed to dry for 1 hour.  The membrane was 
placed in a 3% BSA/0.1% Tween 20 solution diluted in tris-buffered saline (TBS) 
at room temperature for 1 hour.  Anti-Homocysteine rabbit polyclonal antibody 
was diluted 1:5000 in TBST solution and added to membrane for incubation 
overnight at 4°C.  The membrane was then washed with TBST 3 times for 5 
minutes per wash on a rocker at room temperature. Anti-rabbit secondary 
antibody was diluted 1:10,000 in TBST and added to membrane for 1 hour at 
room temperature. The dot blot was then imaged and developed using 
chemiluminescent substrate and analyzed using BioRad ImageLab software 
(Hercules, CA). 
 
Laser Doppler Imaging 
To measure the blood perfusion of the femoral artery, after receiving 
anesthesia, the mice were secured in the supine position and the femoral artery 
of the left hind limb was surgically exposed. Femoral artery perfusion was 
measured using a laser Doppler imager (MoorLDI; Moor Instruments: Devon, 
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UK) for a period of 2 minutes.  The mean perfusion over the 2 minute period was 
calculated and used for analysis.  
 
Ultrasonography 
Ultrasonography was performed before the start of exercise (or control) 
and the day following completion of exercise training (or 6 weeks of control). 
While under isofluorane anesthesia, mice were placed on a warming platform at 
37°C and a commercial hair removal chemical was used to remove all fur from 
the hind limb. Imaging of the femoral artery was performed using a Vevo 2100 
ultrasound Doppler (Visual Sonics, Toronto, ON, Canada).  The femoral artery 
was imaged using a MS550D (22-55 mHz) transducer. The B-Mode imaging 
program was used to obtain clear cross sectional images of the femoral artery 
were obtained to measure the lumen diameter and wall to lumen ratio.   
 
Cryosectioning 
Cryopreserved tissues were stored at -80°C until use. Sections of 8 µM 
thickness were made using a Cryocut tissue sectioner (Leica CM 1850). Cryo-
sections were placed on poly-L-lysine coated microscope slides, air dried and 
stored at -80°C until further use. 
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Collagen Staining 
A Masson’s trichrome staining kit (Richard Allan Scientific; Kalamazoo, 
MI) was used to detect collagen deposition in the gastrocnemius muscle. Cryo-
sections were stained following the manufacturer’s instructions. Collagen 
deposition is displayed as a blue color. All images were captured with an 
Olympus FluoView 1000 light microscope (B&B Microscope Ltd.; Pittsburgh, PA). 
Measurement of collagen content was performed using Image J software (NIH 
free software download). 
 
Reverse Transcription Polymerase Chain Reaction (PCR) 
Total RNA was isolated from mouse gastrocnemius tissue using Trizol 
reagent (Invitrogen; Carlsbad, CA). Purified RNA (1µg) was reverse transcribed 
using the Bio Rad iScript Reverse Transcription system (Hercules, CA) according 
to the manufacturer’s instruction. To amplify specific gene sequences, primers 
were designed and obtained from Invitrogen (Carlsbad, CA). PCR amplification 
was performed for 35 amplification cycles in a Biorad DNA Engine Thermo-cycler 
(Hercules, CA). PCR products were resolved by gel electrophoresis in 1% 
agarose gels. PCR band images were recorded and analyzed using Imagelab 
software (Bio-Rad, Hercules, CA). The band intensities of the PCR product were 
normalized to GAPDH. 
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Real-Time PCR or qPCR 
Reverse transcription of RNA occurs in the same manner as described for 
Reverse Transcriptase PCR. cDNA product, primers, nuclease free water and 
SYBR Green reaction mix (Qiagen; Gaithersburg, MD) were added to wells on a 
96 well plate and the gene sequences were amplified for 55 cycles using a 
Roche Light Cycler.  
 
Western Blotting 
Gastrocnemius tissues were homogenized and lysed in 
radioimmunoprecipitation assay (RIPA) lysis buffer, supplemented with a 
protease inhibitor cocktail, phenylmethanesulfonylfluoride (PMSF) and sodium 
orthovanadate. Lysates were then sonicated for 5 seconds each and then 
centrifuged at 8,000 RPM for 10 minutes. Precipitates (protein) were then 
transferred to a new tube.  Protein concentrations were determined via Bradford 
protein estimation assay to ensure equal protein loading, then samples were run 
on an SDS poly-acrylamide gel in Tris-glycine SDS buffer for proper protein 
separation and were then transferred electrophoretically onto a PVDF membrane 
overnight at 4 degrees.  The membrane was blocked in a 5% milk TBST solution 
for 1 hour. All primary antibodies were diluted at a concentration of 1:1000 in 
TBST and membranes were incubated with primary antibody solution overnight 
at 4 degrees. After primary incubation, the membranes were washed three times 
with TBST solution then incubated with a secondary HRP conjugated antibody 
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solution for 1 hour at room temperature. Membranes were then washed three 
more times with TBST then developed using a chemiluminescent substrate in a 
BioRad Chemidoc (Hercules, CA).  Band intensity was determined using BioRad 
ImageLab software. All proteins of interest were normalized to the values of 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH). 
 
Statistical Analysis 
Statistical analysis was performed using both Microsoft Excel and Primer 
of Biostatistics software. The Primer of Biostatistics software was used to 
perform a one way ANOVA followed by multiple comparisons analysis with 
Bonferroni correction. This analysis was performed on the laser Doppler 
perfusion, mean blood pressure and % collagen measurements to determine 
differences between the means of many groups. Microsoft Excel was used to 
perform a standard t-test to determine mean differences for all other assays. An 
alpha level of p< 0.05 was used to determine statistical significance. All values 
are presented as mean + standard error of the mean.  
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Results 
Plasma Homocysteine Levels 
Using an anti-homocysteine antibody to detect total plasma homocysteine 
and homocysteinylated proteins on a dot blot, it was determined that control 
CBS+/- mice have a 42% greater plasma homocysteine concentration than 
control C57 mice and exercise intervention decreased Hcy levels down to control 
C57 levels. Exercised C57 mice also demonstrated a significant decline in 
plasma Hcy levels (Figure 6). 
 
Body Mass 
At baseline, CBS+/- have significantly reduced body weight when 
compared to C57 and all other mouse models (23.7 vs 27.3 g, respectively). 
CBS/MMP-9 double KO mice are normal bodyweight and not significantly 
different from any group except for CBS+/- mice. After exercise, CBS+/- mice 
gained a significant amount of body weight, but no change was observed in any 
other group. After exercise, CBS+/- mice were no longer significantly 
underweight compared to any other group except for post-exercise MMP-9. In 
CBS+/- mice, the weight of the tibialis anterior (TA) was significantly lower than 
what was observed in the C57 mice. Although exercise did not significantly 
increase the weight of the TA in the CBS+/- mice when compared to the pre-
exercise weight, it was no longer significantly lower than the weight of C57 pre or 
post exercise TA muscles (Figure 7). 
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Blood Pressure Measurements 
CBS+/- mice exhibit significantly higher mean blood pressures than C57 
mice and all other groups (122.0 vs 83.8 mmHg respectively) at baseline. After 6 
weeks, control CBS+/- did not see a significant change in blood pressure due to 
age, but it was still significantly higher than all other groups. However, with 6 
weeks of exercise, mean blood pressure in CBS+/- mice significantly decreased 
when compared to pre-exercise conditions (122.0 vs 87.1 mmHg respectively), 
as well as CBS+/- control conditions and was no longer significantly different 
from any other group.  CBS/MMP-9 mice are normotensive and did not display 
significant differences between any other groups except CBS+/- (Figure 8).   
 
Hindlimb Perfusion 
Perfusion of the femoral artery was significantly lower in CBS+/- control 
mice than every other control group. Perfusion of the femoral artery in 
CBS/MMP-9 mice was not different from any other group except CBS+/-.  With 
exercise training, the perfusion was significantly increased from baseline in every 
group except for CBS/MMP-9, which showed no change. After exercise, 
perfusion in CBS+/- mice was not significantly different from any other post-
exercise group, indicating that perfusion of the hind limb was corrected with 
exercise (Figure 9).  
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Wall to Lumen Ratio and Lumen Diameter 
The wall to lumen ratio, which is inversely correlated to cardiovascular 
health, was significantly elevated in CBS+/- mice when compared to every other 
group at baseline. With exercise intervention, the wall to lumen ratio in CBS+/- 
mice was significantly reduced when compared to baseline (0.36 vs 0.45, 
respectively), indicating that exercise is causing beneficial remodeling of the 
vascular smooth muscle.  However, it was still significantly higher than C57 mice 
at baseline and post-exercise (0.27, 0.24 respectively). No other group saw a 
significant change in wall to lumen ratio with exercise. CBS/MMP-9 mice were 
not significantly different from any other group at baseline, indicating that MMP-9 
may be responsible for the observed remodeling in HHcy.  The lumen diameter 
of the femoral artery was also significantly declined in CBS+/- mice when 
compared to C57 mice at baseline (0.204 mm vs 0.264 mm, respectively), but 
was significantly increased by exercise (0.242 mm). Post-exercise lumen 
diameter in CBS+/- mice was not significantly different from C57 pre or post 
exercise Figure 10).  
 
Collagen Staining 
To determine if the impairments in hindlimb perfusion translated to 
increased fibrosis of the hindlimb skeletal muscle, collagen staining was 
performed on mouse gastrocnemius sections. Indeed, control CBS+/- 
gastrocnemius tissues displayed significantly higher collagen content than 
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observed in every other group (14.0% collagen content vs 2.4% in C57 controls). 
After exercise intervention, CBS+/- collagen content significantly fell to 2.8%, 
making it insignificant from C57 controls or C57+exercise. FVB, MMP-9 and 
CBS/MMP-9 control groups were all slightly, but significantly higher than C57 
controls. MMP-9 mice saw a decline in muscle collagen content with exercise 
training, but, besides CBS+/-, the other groups did not. Although CBS/MMP-9 
control mice had significantly higher collagen content in their gastrocnemius than 
C57 at controls, they were not different from FVB and MMP-9 controls (Figure 
11).   
 
CBS +/- Mice Have Impaired Metabolic Activity in the Skeletal Muscle 
 Cytochrome C oxidase is the last enzyme in the electron transport chain 
and is crucial for oxidative metabolism. Using PCR, it was determined that 
control CBS+/- mice display 20% lower cytochrome C oxidase mRNA in the 
gastrocnemius muscle when compared to C57 controls, indicating lower skeletal 
muscle metabolic activity in CBS+/- mice. However, with exercise training, mRNA 
levels were significantly increased to the same levels as expressed in C57. There 
was no change observed in C57 with exercise (Figure 12).  
 
Hyperhomocysteinemia Induces Myostatin 
 Western blotting analysis of the gastrocnemius tissue demonstrated that 
control CBS+/- mice have a 2 fold increase in myostatin levels when compared to 
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C57 controls, indicating that CBS+/- mice have impaired muscle growth 
compared to their wild type counterparts. Although myostatin demonstrated a 
general decline with exercise in CBS+/- mice, it was not quite significant (p = 
0.055). Surprisingly, C57 mice demonstrated a significant increase in myostatin 
levels with exercise when compared to the control group. However, post-exercise 
myostatin levels in C57 and CBS+/- tissues were almost identical (1.35 vs 1.39 
fold increase from C57 controls respectively), with no significant differences 
between the two values.  CBS/MMP-9 control levels were not significantly 
different from C57 controls (Figure 13).  
 
Exercise Increases Follistatin mRNA Expression 
 PCR analysis of the gastrocnemius tissues indicated that exercise 
significantly increased follistatin mRNA expression in C57 and CBS+/- muscle by 
2.5 and 3 fold respectively, when compared to their non-exercise counterparts. 
However, although control CBS+/- mice displayed a trend for lower follistatin 
expression compared to C57 controls, the value was not significantly less 
(p=0.08). Values for CBS+/- mice with exercise were significantly higher than 
control C57 values, but not significantly different from C57 with exercise (Figure 
13). 
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Hyperhomocysteinemia Induces Markers of Hypoxia 
 Western blotting revealed that control CBS+/- mice express significant 
increases in VEGF and iNOS protein when compared to C57 controls (1.32 and 
1.44 fold increase, recpectively). As expected, exercise increased both VEGF 
and iNOS in C57 mice compared to their control counterparts (1.20 and 1.38 fold 
increase, respectively). In exercised CBS+/- mice, VEGF was significantly 
reduced while iNOS did not change when compared to CBS+/- controls, with 
VEGF being reduced to C57 control levels. VEGF in CBS+/- exercise mice was 
also significantly lower than C57 exercise mice. CBS+/- exercise mice expressed 
greater iNOS than C57 controls as well, but it was not significantly different from 
exercised C57 (Figure 14).  
 
Hyperhomocysteinemia Induces EMMPRIN and MMP-9 
EMMPRIN protein, a known inducer of MMP’s, was upregulated in CBS+/- 
control gastrocnemius muscle compared to C57 controls (1.53 fold increase). 
Exercise significantly reduced CBS+/-exercise EMMPRIN levels, while increasing 
C57 exercise levels compared to their non-exercise counterparts (1.30 and 1.37 
fold increase over C57 controls, respectively). CBS+/- and C57 exercise groups 
were not significantly different from one another.  Not surprisingly, MMP-9 mRNA 
expression was significantly higher in CBS+/- controls compared to C57 controls 
(0.171 vs 0.047 respectively) and was significantly reduced with exercise (0.030).  
However, there were no significant differences between the control and exercise 
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C57 groups or CBS+/- exercise. Interestingly, despite the difference in mRNA 
expression, MMP-9 protein expression followed a very similar pattern to 
EMMPRIN protein expression. MMP-9 was significantly higher (almost 2 fold) in 
CBS+/- controls than C57 controls and was significantly reduced with exercise. 
Exercise increased MMP-9 levels in the C57 exercise group and there was no 
significant difference between this group and the CBS+/- exercise group (Figure 
15).  
HHcy Promotes Inflammation in CBS+/- Skeletal Muscle 
 PPAR-γ protein expression, a pro-antioxidant factor, is significantly 
decreased in the skeletal muscle of CBS+/- controls compared to C57 controls 
(14% lower). Interestingly, it is significantly declined in CBS+/- and C57 exercise 
groups when compared to their respective control counterparts. Protein 
expression of IL-1β, a pro-inflammatory cytokine, is significantly increased in 
CBS+/- control gastrocnemius tissue compared to C57 controls (46% higher). 
Interestingly, there is a trend suggesting that these molecules may increase in 
the muscle with exercise in both groups, but due to variability, neither of these 
values are significantly different from their controls (Figure 16).  
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Figure 6: Elevated plasma Hcy levels in CBS +/- mice are decreased with 
exercise. Representative dot blot image of Hcy levels in mouse plasma samples. 
Plasma Hcy levels were significantly higher in CBS NE compared to C57 NE (p< 
0.001); these levels were decreased in CBS ET compared to CBS NE (p< 0.001). 
Plasma Hcy was also lowered in C57 ET mice compared with C57 NE (p< 
0.005).  Band density was quantitated using BioRad Image Lab software. Data 
are shown as ± SEM. n= ≥ 3.  
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Figure 7: HHcy leads to decreased body mass and muscle mass, but is 
mitigated by exercise training. The above data show that A) CBS +/- mice 
have lower body weight compared to all other mouse groups used;  B) exercise 
training mitigates the weight difference between CBS+/- and WT; and C) TA 
mass is significantly lower in CBS +/- NE when compared to C57 NE, but 
exercise training mitigates this weight difference.  Data are displayed as mean ± 
SEM.  n= ≥ 3; p< 0.05. * = different from corresponding control group;  # = 
different from C57 NE. 
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Figure 8: Exercise training mitigates HHcy induced hypertension. The 
above data are a representation of mean blood pressure measures for all mouse 
groups at baseline, after 6 weeks of control and after 6 weeks of exercise. CBS 
+/- mice have significantly higher mean blood pressure than every other group at 
baseline and this is completely mitigated after 6 weeks of exercise. Data are 
represented as mean ± SEM. n ≥ 3; p< 0.05. * = different from corresponding 
control group;  # = different from C57 NE. 
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Figure 9: HHcy causes impaired hind limb perfusion that is mitigated with 
exercise training. Femoral artery perfusion is decreased in CBS NE compared 
to C57 NE and is significantly increased with exercise. Flux was measured using 
a laser Doppler imager. Data are represented as mean ± SEM. n ≥ 3; p< 0.05;     
* = different from corresponding control group;  # = different from C57 NE.  
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Figure 10: HHcy causes an increased wall to lumen ratio and a decreased 
lumen diameter, but these effects are reversed with exercise training.  At 
baseline, CBS +/- mice have a significantly higher femoral artery A) wall to lumen 
ratio and significantly lower B) lumen diameter when compared to C57 pre-
exercise. Exercise mitigates these effects. Data are represented as mean ± 
SEM. n ≥ 3; p< 0.05.  
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Figure 11: Exercise training mitigates HHcy induced skeletal muscle 
fibrosis. Control CBS +/- mice have a significantly higher % of total collagen in 
the gastrocnemius than every other group. Exercise training reverses this. FVB, 
MMP-9 and CBS/MMP-9 control groups all have higher total collagen content 
than C57 NE. These are FVB based, which is a different mouse breed.  Data are 
represented as mean ± SEM. n ≥ 3; p< 0.0005 vs C57 NE and CBS ET. 
63 
 
 
 
 
Figure 12: HHcy causes decreased oxidative metabolism in skeletal 
muscle, but it is improved by exercise. Cytochrome C oxidase mRNA 
expression is lower in control CBS +/- gastrocnemius muscle compared to C57 
control. Exercise training increases Cytochrome C oxidase expression in CBS +/- 
mice. The mRNA expressions were determined through densitometry analysis. 
Data are represented as mean ± SEM. n ≥ 4; p< 0.0005; 0.05,  vs C57 NE and 
CBS ET, respectively. * = different from corresponding control group;  # = 
different from C57 NE 
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Figure 13: HHcy alters skeletal muscle growth regulators and exercise 
training reverses the effects. A) Myostatin protein expression is elevated in 
CBS NE gastrocnemius compared to C57 NE and the expression is normalized 
with exercise. B) Follistatin expression is increased in C57 and CBS mice with 
exercise in comparison to their respective controls. Densitometry analysis was 
used for band quantitation. Data are represented as mean ± SEM. n ≥ 4; p< 0.01, 
0.05 for CBS NE vs C57 NE and CBS NE VS CBS ET, respectively for 
myostatin. p< 0.01 for CBS ET vs CBS NE for follistatin.  * = different from 
corresponding control group;  # = different from C57 NE 
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Figure 14: HHcy induces hypoxia in skeletal muscle. VEGF and iNOS protein 
expression are elevated in control CBS +/- mice when compared to C57 NE, 
indicating baseline hypoxia.  Exercise decreases VEGF expression in CBS +/- 
mice to C57 NE levels. Band density was determined through densitometry 
analysis. Data are represented as mean ± SEM. n ≥ 4; p< 0.0001, 0.0005 for 
CBS NE vs C57 NE and CBS NE VS CBS ET, respectively for VEGF. p< 0.005 
for CBS NE vs C57 NE for iNOS. 
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Figure 15: Exercise training mitigates HHcy induction of EMMPRIN and 
MMP-9.  A) EMMPRIN protein and MMP-9 B) protein and C) mRNA are induced 
in control CBS +/- gastrocnemius compared to C57 NE.  Exercise causes a 
significant decrease in all three of these values. Data are represented as mean ± 
SEM. n ≥ 4; p< 0.005, 0.05 for CBS NE vs C57 NE and CBS NE VS CBS ET, 
respectively for EMMPRIN. p< 0.005, 0.05 for CBS NE vs C57 NE and CBS NE 
VS CBS ET, respectively for MMP-9.  p< 0.05, 0.01 for CBS NE vs C57 NE and 
CBS NE VS CBS ET, respectively for MMP-9 mRNA.  
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Figure 16: HHcy creates inflammatory environment in skeletal muscle.      
A) PPAR-γ protein expression is reduced and B) IL-1β protein expression is 
increased in CBS+/- mice compared with C57 NE.  Data are represented as 
mean ± SEM. n ≥ 4; p< 0.0005 for CBS NE vs C57 NE for PPAR-γ.  p< 0.005 for 
CBS NE vs C57 NE IL-1β.  
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Discussion 
 HHcy is implicated in diseases such as atherosclerosis, heart disease and 
diabetes and is thought to cause multi-organ damage (Bortolotto et al., 1999; 
Miller et al., 2000; Signorello et al., 2007; Sutton-Tyrrell et al., 1997; Zheng et al., 
2013). Recent research has demonstrated that HHcy results in impaired 
responsiveness to ischemia/reperfusion injury, lower muscle strength and 
functionality, increased fatigability and lower muscle ATP levels (Swart et al., 
2013; Sudhakar Veeranki et al., 2014; S. Veeranki et al., 2015).  However, the 
effects of regular exercise on cardiovascular disease and skeletal muscle 
function are known to be very beneficial. It has also been established that 
exercise has the capability of reducing homocysteine levels (Neuman et al., 
2013; Randeva et al., 2002).  Nevertheless, despite the abundance of research 
on HHcy, there is very little information available regarding the molecular 
changes that HHcy induces in the skeletal muscle tissue and there is even less 
information available regarding the effects of exercise on these changes .The 
present study demonstrates that HHcy induces skeletal muscle fibrosis through 
induction of inflammatory factors and impairment of perfusion. This study 
demonstrates that exercise is capable of attenuating most of these effects.  
 In this study, CBS +/- (HHcy) mice displayed a 13.2% decrease in body 
weight, decreased skeletal muscle weight and a 42% increase in plasma 
homocysteine levels when compared to C57 (WT) mice. These findings agree 
with previous clinical studies that found patients with HHcy due to genetic defects 
to have a significant reduction in body weight and muscle mass (Kalra et al., 
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1985; Kanwar et al., 1976).  Dot blot analysis determined that CBS +/- mice do in 
fact have a 42% greater concentration of plasma homocysteine and 
homocysteinylated proteins when compared to C57 mice. CBS +/- mice also 
demonstrated a significant elevation in mean blood pressure, placing them well 
above normal levels (122 mmHg).  Not surprisingly, this elevation in blood 
pressure was accompanied by significant reductions in luminal diameter and 
perfusion of the femoral artery as well as a significant increase in wall to lumen 
ratio. This data indicates that HHcy is likely inducing adverse remodeling of the 
vascular smooth muscle, causing a thicker and less compliant vascular wall 
which will cause elevated blood pressure. Our data agrees with previous findings 
from our laboratory that suggests that CBS +/- mice demonstrate a blunted 
response to ischemia/reperfusion injury after femoral artery ligation (Veeranki et 
al., 2014). The CBS +/- mice demonstrated impaired development of collateral 
vessels in the ischemic hind limb due to impaired angiogenesis, which was 
caused by blunted elevation of pro-angiogenic factors such as VEGF, HIF1-α and 
PGC-1α.  Our findings are also supported by other studies which demonstrate 
that HHcy is associated with increased intraluminal thrombus thickness, aortic 
stiffness, systolic hypertension and myocardial impairment (Bortolotto et al., 
1999; Sutton-Tyrrell et al., 1997; Wiernicki et al., 2011; Zheng et al., 2013). 
Bortolotto et al. demonstrated that in 236 hypertensive patients, individuals with 2 
or 3 sites of clinical vascular disease had significantly higher plasma 
homocysteine levels than hypertensive patients with no clinical vascular disease 
(Bortolotto et al., 1999). Accompanying impaired angiogenesis and vascular 
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disease, other studies demonstrate that Hcy promotes the formation of ROS and 
diminishes nitric oxide production in the vasculature, which are both associated 
with impaired endothelial responsiveness and hypertension (Signorello et al., 
2007; Tyagi et al., 2009). 
 With HHcy causing impaired perfusion to the hind limb and skeletal 
muscle weakness, it would seem likely that the skeletal muscle in CBS +/- mice 
would display signs of fibrosis. Indeed, this study demonstrated that the CBS +/- 
gastrocnemius muscle displayed a 6 fold increase in skeletal muscle collagen 
deposition when compared to C57 controls. Excessive collagen deposition, which 
is a hallmark of muscular fibrosis, leads to increased rigidity and decreased 
functionality of skeletal muscle (Dodd et al., 2014; Gillies & Lieber, 2011).  These 
findings support other studies that suggest that HHcy induces skeletal muscle 
weakness and impaired functionality, which could clearly be caused by muscular 
fibrosis (Swart et al., 2013; Veeranki et al., 2015). 
 Interestingly, this data demonstrates that with implementation of a 6 week 
treadmill exercise program these CBS +/- mice demonstrate increased weight 
gain, muscle mass, femoral artery perfusion and lumen diameter.  This study 
also found a complete reversal of the plasma homocysteine levels, hypertension 
and collagen deposition as well as a decrease in the CBS +/- wall to lumen ratio. 
Furthermore, CBS/MMP-9 double KO mice did not exhibit any of these issues. 
CBS/MMP-9 mice are normal weight and have normal blood pressure, perfusion 
and wall to lumen ratio as well as significantly lower collagen deposition in the 
skeletal muscle than observed in the CBS +/- mice.  Although there were 
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insufficient plasma samples for statistical analysis, it appears that the CBS/MMP-
9 mice have similar homocysteine levels to the CBS +/- mice (1.45 vs 1.43 fold 
increase compared to C57 control, respectively).  This data suggests that Hcy 
elicits the majority of its associated pathologies through hyperactivity of MMP-9, 
which is known for its ability to degrade the ECM.   
  The findings that exercise reverses the effects of HHcy on skeletal 
muscle dysfunction agree with other studies that exercise decreases or prevents 
increases in plasma Hcy levels (Neuman et al., 2013; Randeva et al., 2002). 
Data from this study supports findings from the lab’s previous study, which 
suggests that swimming exercise can attenuate the effects of HHcy on the down-
regulation of mitochondrial transcription factors and ATP production in the 
skeletal muscle (Veeranki et al., 2015). This evidence suggests that CBS +/- 
mice have impaired skeletal muscle metabolism when compared to control mice 
and that exercise can improve its metabolic function. This study further supports 
this theory by demonstrating that CBS +/- mice have a decrease in 
gastrocnemius cytochrome c oxidase mRNA expression compared to C57 
controls. It was found that exercise completely reverses this metabolic deficit.   
 With a decreased mass, elevated fibrosis and impaired metabolic activity 
in CBS +/- skeletal muscle, I wanted to determine whether or not the skeletal 
muscle growth was being impaired by changes in molecular growth factors. The 
data suggests that CBS +/- gastrocnemius muscle had a 2 fold increase in 
expression of myostatin protein, a muscle growth inhibitor, when compared to 
C57 controls. CBS/MMP-9 myostatin expression was significantly lower than 
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levels in CBS +/- mice and was not different from levels in C57 controls, once 
again confirming that MMP-9 induction is likely the mechanism of action for 
HHcy.  As expected, myostatin levels in CBS +/- mice were significantly reduced 
with exercise and were reduced to the same levels as seen in exercised C57 
mice, which correspond well with the findings that exercise increases follistatin 
mRNA expression in CBS +/- mice. Interestingly, there was an observed increase 
in myostatin levels in C57 exercise mice compared to their control counterparts.  
The observed significant increase in follistatin mRNA expression, a known 
inhibitor of myostatin, in C57 mice with exercise suggests that myostatin may be 
over-expressed in C57 mice post-exercise due to positive feedback loops from 
myostatin inhibition during exercise. This exercise protocol was designed for 
moderate to high intensity by the end of the protocol to ensure muscular 
hypertrophy as seen in some resistance training programs. Findings that 
myostatin increased in the skeletal muscle of C57 mice with exercise training is 
supported by findings from Willoughby, 2004.  This author found that 12 weeks of 
resistance training in 22 healthy males resulted in elevated body mass, muscle 
mass and strength, but also demonstrated increases in myostatin mRNA, 
myostatin and follistatin-like related gene, another inhibitor of myostatin 
(Willoughby, 2004). Furthermore, unchecked myostatin levels, as seen in control 
CBS +/- mice, has been shown to directly increase fibroblast activity, which in 
turn, increases macrophage activity (McCroskery et al., 2005; Vidal et al., 2008). 
Seeing as both macrophages and fibroblasts are implicated in muscular fibrosis, 
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it makes sense that control CBS +/- mice, which over-express myostatin, would 
have fibrotic muscle tissue.  
 The findings that VEGF and iNOS are induced in the gastrocnemius 
muscle of control CBS+/- mice and exercised C57 mice is not surprising, as both 
are commonly induced during states of hypoxia, including exercise (Forsythe et 
al., 1996; Hambrecht et al., 1999; Richardson et al., 1999; Richardson et al., 
2000; Shweiki, Itin, Soffer, & Keshet, 1992; Vogt et al., 2001). However, it was 
interesting to see that VEGF was decreased to C57 control levels in exercise 
CBS+/- mice. A study from Richardson et al. demonstrates that exercise training 
causes a reduction in VEGF stimulation when exposed to hypoxic conditions, 
suggesting that VEGF stimulation has a negative feedback mechanism 
(Richardson et al., 2000).  It is plausible that CBS +/- muscle tissue has become 
insensitive to VEGF stimulation and with training, angiogenesis has occurred 
through an elevated stimulation of other angiogenic factors such as fibroblast 
growth factor, causing a decline in VEGF necessity. Furthermore, an increased 
capillary to fiber ratio, as observed with exercise training, would decrease the 
basal level of hypoxia in the muscle tissue, resulting in a decrease in VEGF 
production.   
 As expected with HHcy, MMP-9 mRNA and protein expression as well as 
protein expression of its inducer, EMMPRIN, were all significantly elevated in 
CBS+/- mice when compared to C57 controls. Interestingly, EMMPRIN and 
MMP-9 protein levels are both significantly increased with exercise training in 
C57 mice.  Although MMP-9 has been associated with numerous diseases, it has 
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also been demonstrated that MMP-9 assists with satellite cell translocation 
(Kherif et al., 1999; Lewis et al., 2000; Zimowska et al., 2008) and may be 
required for the onset of angiogenesis (Bellafiore et al., 2013; Mackey et al., 
2004; Rullman et al., 2009).  However, this does not explain why EMMPRIN and 
MMP-9 protein expression is decrease in exercise CBS+/- mice compared to 
control CBS+/-. Seeing as exercise decreased these values to levels that are 
almost identical to exercised C57 values, it would seem that basal levels of these 
proteins in CBS+/- mice were more than sufficient to accomplish necessary 
growth associated tasks for exercise, allowing for normalization of their values.  
Although protein expression of MMP-9 went up with exercise in C57 mice, the 
data demonstrates a decrease in MMP-9 mRNA values. Since the animals were 
sacrificed 2 days post-exercise to allow time for blood pressure and 
ultrasonography data to be collected, it is plausible that the elevated MMP-9 
protein expression elicited a reduction in MMP-9 mRNA via negative feedback 
during that time frame. 
 To assess other markers of inflammation, changes in IL-1β, a pro-
inflammatory cytokine, and PPAR-γ, a pro-antioxidant, protein expressions in the 
gastrocnemius tissue were measured. In CBS+/- mice, IL-1β was elevated and 
PPAR-γ was decreased when compared to C57 control mice, as expected with 
HHcy. It is well known that Hcy induces inflammation and it has been 
demonstrated that it also inhibits PPAR-γ (Mujumdar et al., 2002). Interestingly, 
this data suggests that PPAR-γ is decreased with exercise in both C57 and CBS 
+/- groups. These results agree with a data from Tunstall et al. that demonstrated 
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a significant reduction in PPAR-γ in human vastus lateralis muscle after 9 days of 
60 minute cycling bouts (Tunstall et al., 2002). With exercise requiring 
inflammation for proper growth and repair during the recovery phase, as seen in 
elevated levels of MMP-9 and EMMPRIN, it is plausible that a potent pro-
antioxidant like PPAR-γ would be down-regulated to allow for adequate induction 
of the inflammatory process. Although the elevations are insignificant, the slight 
increases in IL-1β observed with exercise would support this theory.  
 In summary, results of this study indicate that HHcy causes muscle 
dysfunction that is induced through multiple anti-proliferative and inflammatory 
factors such as myostatin, EMMPRIN and MMP-9. It would appear that MMP-9 is 
a primary pathway through which HHcy causes pathological conditions since 
CBS/MMP-9 double KO mice have elevated Hcy levels, but do not display any of 
the pathological conditions that are witnessed in CBS+/- mice. Furthermore, 
exercise was capable of mitigating most of the pathological complications 
associated with HHcy.  Clearly, further research on the exact mechanism of 
action for HHcy induced skeletal muscle dysfunction needs to be conducted.  
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CHAPTER V 
THE EFFECT OF HYPERHOMOCYSTEINEMIA ON MACROPHAGE 
DIFFERENTIATION AND SKELETAL MUSCLE INFILTRATION 
 
Introduction 
Homocysteine has been widely identified as a risk factor in numerous 
disease states. HHcy, demonstrating plasma Hcy levels >15 µmol/L, has known 
prevalence in hypertension, stroke, cardiovascular disease and skeletal muscle 
dysfunction (Bortolotto et al., 1999; Hayden & Tyagi, 2004; Mujumdar et al., 
2002; Signorello et al., 2007; Sutton-Tyrrell et al., 1997; Tyagi et al., 2005;  
Veeranki & Tyagi, 2013). Research has shown a direct correlation between 
plasma Hcy levels and aortic pulse wave velocity, intraluminal thrombus 
thickness and arterial stiffness.  
It is well established that Hcy elicits many of its detrimental effects through 
increased ROS production and through induction of MMP-9 (Hayden & Tyagi, 
2004; Lee et al., 2012; Signorello et al., 2007; Tyagi et al., 2009). MMP-9 is an 
endoproteinase that is known to degrade components of the extracellular matrix, 
such as elastin and collagen type IV. Excessive MMP-9 activity has been 
associated with endothelial dysfunction and vascular
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remodeling, leading to diseases such as atherosclerosis (Onal et al., 2009; 
Wiernicki et al., 2011; Yasmin et al., 2005).  More recently it has been discovered 
that MMP-9 production and activity are increased through an EMMPRIN 
mediated pathway involving NF-κB (Ge et al., 2007; Major et al., 2002; Reddy et 
al., 2010; Yoon et al., 2005; Zhu et al., 2005).  EMMPRIN is a glycoprotein that 
can be induced through inflammatory factors such as IL-18.  In a study involving 
human carotid endarterectomy specimens, significant EMMPRIN 
immunoreactivity was displayed in atherosclerotic carotid lesions, arterial plaque 
and in macrophage infiltrates of the atherosclerotic intima (Yoon et al., 2005).  
This same study also examined the effects of atherogenic pro-inflammatory 
cytokines (TNF-α, IL-6 and IL-1β) on cultured human bone marrow monocytes 
and discovered increased expression of EMMPRIN protein and increased MMP-
9 activity.  
With the numerous pathological effects of HHcy revolving around ECM 
degradation, vascular remodeling, cardiovascular disease and inflammation, it is 
important to ponder the effects of Hcy on macrophages, the body’s main innate 
immune cells. It is well established that macrophages have two specific 
subtypes, denoted as M1 and M2. The M1 phenotype is the destructive, 
“classically activated” subset, while the M2 is called the “alternatively activated” 
subset, associated with growth and repair (Mills, 2012; Sica & Mantovani, 2012). 
Although classically activated macrophages are important for fighting infections, 
previous research has demonstrated that excessive macrophage differentiation 
into the M1 phenotype can cause chronic adipocyte inflammation, neurotoxicity 
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to injured nerves and damage the arterial vasculature (Kigerl et al., 2009; Oh et 
al., 2012; Tavakoli & Asmis, 2012; Zeyda et al., 2007).  It has been demonstrated 
that M1 macrophages elicit their inflammatory and damaging effects through a 
rapid production of ROS, NO and MMP-9 (Mills, 2012; Sica & Mantovani, 2012; 
Woo, Lim, & Kim, 2004).  Interestingly, It has been demonstrated that Hcy 
induces vascular endothelial growth factor expression and monocyte 
chemoattractant protein-1 via an NF-κB dependent pathway in THP-1 
macrophages, which are both associated with vascular disease progression 
(Wang et al., 2001). There are several markers that have been used to detect M1 
and M2 macrophages, however, Vogel et al. clearly demonstrate that CD40, a 
cell surface co-stimulatory protein found on macrophages, is a highly effective 
marker for detection of the M1 phenotype (Vogel et al., 2013).   
In the skeletal muscle, macrophages are crucial for proper growth and 
repair.  Once macrophages phagocytose muscle cell debris, they shift towards 
and anti-inflammatory profile, causing the release of TGF-β and bFGF, which 
stimulates muscle satellite cell migration (Arnold et al., 2007; Robertson et al., 
1993). Injury to the skeletal muscle elicits significant increases in macrophage 
infiltration for 3 days post injury then these levels begin to subside by day 6 
(Pimorady‐Esfahani et al., 1997).  If monocyte recruitment to the site of damaged 
skeletal muscle is interrupted within the first 24 hours post-injury, the repair 
process is completely attenuated. Inflammatory macrophages stimulate 
myogenic cell proliferation, while anti-inflammatory macrophages stimulate 
myogenic cell differentiation into myotubes (Arnold et al., 2007). Complete 
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removal of macrophages after muscular injury decreases the diameter of 
regenerating muscle fibers (Arnold et al., 2007; Chazaud et al., 2009). Research 
demonstrates that exercise stimulates the phagocytic activity of macrophages 
(De la Fuente et al., 1990; Ferrandez & De la Fuente, 1999). However, the 
effects of exercise on macrophage differentiation and infiltration into the skeletal 
muscle, especially in a chronically inflammatory environment, have not been 
well-documented. Kawanishi et al. demonstrated that mice being fed a high fat 
diet display a greater ratio of adipose tissue M1/M2 macrophages compared to 
normal diet controls (Kawanishi et al., 2010). After 16 weeks of exercise training, 
there was a decreased ratio of M1/M2 macrophages in the high fat diet group 
due to increased presence of M2 macrophages. This was accompanied by a 
decrease in TNF-α mRNA expression, which is only expressed by M1 
macrophages.  
There have been no other studies that determine whether Hcy alters 
macrophage differentiation through EMMPRIN or if chronic HHcy leads to 
increased M1 macrophage infiltration into skeletal muscle. Therefore, it is the 
purpose of this study to determine the effects of homocysteine on the phenotypic 
differentiation of macrophages and whether or not it increases M1 macrophage 
presence in skeletal muscle tissue.   
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Methods 
Chemicals and Antibodies 
L-homocysteine was purchased from Sigma-Aldrich (St. Louis, MO).  
EMMPRIN, CD40, F4/80 and all HRP-conjugated secondary antibodies were 
purchased from Santa Cruz Biotechnology (Dallas, TX).  GAPDH antibody was 
purchased from EMD Millipore (Billerica, MA).   MMP-9 and TNF-α antibodies 
were purchased from Abcam (Cambridge, MA) and fluorescent secondary 
antibodies were purchased from Life Technologies (Carlsbad, CA).  
 
Animal Care and Exercise Protocol 
 C57 and CBS +/- mice were used for this study. Animal care and the 
exercise protocol are as previously described in Chapter IV.  
 
Cell Culture 
J774A.1 and Raw 264.7 murine macrophages cell lines were obtained 
from ATCC (Manassas, VA). Cells were grown in 75cm2 flasks using ATCC 30-
2002 Dulbecco’s Modified Eagles Medium (DMEM) supplemented with 10% fetal 
bovine serum (FBS) and 1% final volume penicillin-streptomycin solution. Cells 
were maintained in a 37 °C incubator with 5% CO2 and passaged by scraping 
cells into fresh medium per ATCC recommendations.  
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Cell Treatment 
Cells were plated in 6 well plates at a count of 750K cells per well for 
harvesting of protein or in 8 well chamber slides at a count of 150K cells per 
chamber for Immunocytochemistry. After 24 hours of incubation, to allow for 
proper plate adherence, the medium was aspirated and fresh medium was added 
to each well.  Homocysteine treatment was added directly to the medium at a 
final concentration of 500μM for Raw 264.7 cells and 100μM for J774A.1 cells.  
Cells were then incubated with Hcy treatment for 24 hours.  
 
Western Blot Analysis 
Gastrocnemius tissue was used for protein analysis. For cell culture 
experiments, cells were harvested 24 hours after Hcy treatment for protein 
analysis.  The DMEM medium was aspirated and cells were then washed twice 
with PBS. Cells or gastrocnemius tissues were then lysed in RIPA lysis buffer, 
supplemented with a protease inhibitor cocktail, PMSF and sodium 
orthovanadate, for 15 minutes on ice. For cell culture, each well was then 
scraped and contents were transferred to an Eppendorf tube. Cell culture and 
gastrocnemius lysates were then sonicated for 5 seconds each and then 
centrifuged at 8,000 RPM for 10 minutes. Precipitates were then transferred to a 
new tube.  Protein concentrations were determined via Bradford protein 
estimation assay to ensure equal protein loading then samples were run on an 
SDS poly-acrylamide gel in Tris-glycine SDS buffer for proper protein separation 
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and were then transferred electrophoretically onto a PVDF membrane overnight 
at 4 degrees.  The membrane was blocked in a 5% milk TBST solution for 1 
hour. All primary antibodies were diluted at a concentration of 1:1000 in TBST 
and membranes were incubated with primary antibody solution overnight at 4 
degrees. After primary incubation, the membranes were washed three times with 
TBST solution then incubated with a secondary HRP conjugated antibody 
solution for 1 hour at room temperature. Membranes were then washed three 
more times with TBST then developed using a chemiluminescent substrate in a 
BioRad Chemidoc (Hercules, CA).  Band intensity was determined using 
densitometry analysis.  
 
DCFDA ROS Assay 
To detect changes in ROS production levels between control and Hcy 
treated cells, cells were aspirated 24 hours post treatment and fresh medium 
containing 20μM 2’,7’ –dichlorofluorescin diacetate (DCFDA) was added to each 
well. For EMMPRIN inhibition ROS assay, anti-EMMPRIN antibody was diluted 
1:200 in complete DMEM medium and added 2 hours prior to treatment. Cells 
were incubated with DCFDA at 37 degrees for 30 minutes. The medium was then 
aspirated and each well was washed 3 times with PBS. Fresh PBS was then 
added to each well and the cells were imaged using confocal microscopy.  
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Immunocytochemistry 
After cell treatment, the medium was aspirated from each well of the 
chamber slides and they were then washed twice with PBS. Cells were then fixed 
using a 4% paraformaldehyde solution for 15 minutes at room temperature, 
which was followed by 3 washes with PBS. A PBS solution with 3% BSA and 
0.3% Triton X-100 was used to block non-specific binding and permeabilize the 
cells for 1 hour. Primary antibody was then added in a concentration of 1:50 for 
CD40 and 1:200 for MMP-9 in a PBS solution containing 1% BSA and 0.1% TX-
100 and was incubated overnight at 4°C. The chamber slides were aspirated, 
washed 3 times and then incubated with fluorescent secondary antibody (1:200) 
for 2 hours at room temperature.  Chambers were then washed 3 times and then 
a DAPI staining solution was added for 5 minutes, followed by 3 more washes. 
Confocal Microscopy was then used to detect fluorescence.  
 
EMMPRIN Antibody Treatment 
To assess the role of EMMPRIN on M1 macrophage differentiation, prior 
to homocysteine treatment, EMMPRIN antibody was added in a final 
concentration of 1:200 directly to the cell culture medium to inhibit EMMPRIN 
function. Cells were allowed to incubate with antibody for 2 hours and then the 
homocysteine treatment was administered as described above.  
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Immunohistochemistry 
Tissues were cryo-sectioned onto poly-L-lysine coated glass microscope 
slides and allowed to air dry. Slides were stored at -80°C until use. Slides were 
dipped in deionized water to remove tissue freezing medium from slide. Tissue 
sections were then fixed using a 4% paraformaldehyde solution for 15 minutes at 
room temperature, which was followed by 3 washes with PBS. A PBS solution 
with 3% BSA and 0.3% Triton X-100 was used to block non-specific binding and 
permeabilize the cells for 1 hour. Primary antibody was then added in a 
concentration of 1:50 in a PBS solution containing 1% BSA and 0.1% TX-100 
and was incubated overnight at 4°C. The slides were then washed 3 times and 
then incubated with fluorescent secondary antibody (1:200) for 2 hours at room 
temperature.  Slides were then washed 3 times and then a DAPI staining solution 
was added for 5 minutes, followed by 3 more washes. Confocal Microscopy was 
then used to detect fluorescence. Fluorescent intensity was then quantitated 
using Image J software (NIH).  
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RESULTS 
Hcy treatment induces EMMPRIN expression 
Since EMMPRIN is suggested to be an inducer of matrix 
metalloproteinases, we decided to look at changes in EMMPRIN protein 
expression with Hcy treatment in these cells lines. Western blotting was used to 
determine changes in EMMPRIN expression. EMMPRIN was significantly 
increased in RAW 264.7 cells with 24 hours of 500 μM Hcy treatment when 
compared with controls (p< .001).  In J774A.1 cells, a significant induction (p< 
.05) of EMMPRIN protein with 24 hours of 100 μM Hcy treatment was also 
observed (Figure 17);  n=3.  
 
Hcy treatment induces ROS production in macrophages 
Since M1 macrophages are associated with increased reactive oxygen 
species (ROS) production, we utilized a DCFDA (2’,7’ –dichlorofluorescin 
diacetate) assay to determine if Hcy treatment causes increased ROS production 
in both strains of murine macrophages. Both RAW 264.7 and J774A.1 cells 
demonstrated increased ROS production (p< .05; p< .01) after 24 hours of 
500μM and 100μM Hcy treatment respectively, when compared with controls 
(Figure 18); n=3.   
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Hcy treatment induces MMP-9 protein 
To determine whether or not MMP-9 was elevated in Hcy treated cells, 
immunocytochemistry (ICC) was performed on both cell lines to determine 
changes in expression of MMP-9 protein.  After 24 hours of 100μM Hcy 
treatment, the J774A.1 cells displayed a significantly higher (p< .05) production 
of MMP-9 protein when compared with controls.  Raw 264.7 cells incubated with 
500μM Hcy treatment for 24 hours also displayed elevated levels of MMP-9 
protein (p< .05).  Fluorescent intensity was measured to quantitate these 
increases in MMP-9 production (Figure 19); n=3. 
 
HCY Treatment Induces CD40 in murine macrophages 
To determine the effect of Hcy on macrophage phenotype differentiation, 
J774A.1 and Raw 264.7 cells (mouse macrophage cell lines) were stimulated 
with Hcy treatment for 24 hours.  Cells were harvested and lysed for protein 
analysis and analyzed through western blotting.  CD40 was significantly 
increased (p<0.05) in J774A.1 cells with 100μM Hcy treatment.  The Raw 264.7 
cells were not as sensitive to Hcy treatment as the J774A.1 cell line, but 
displayed a significant 2.24 fold increase (p< 0.0001) in CD40 protein with 500uM 
Hcy treatment (Figure 20); n=3.   
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Inhibiting EMMPRIN activity decreases the M1 macrophage phenotype 
In order to determine if EMMPRIN is involved in differentiation of 
macrophages into the M1 phenotype, we decided to see if blocking EMMPRIN 
function would impact CD40 protein expression.  RAW 264.7 and J774A.1 cells 
were incubated with anti-EMMPRIN antibody for 2 hours prior to no HCY 
treatment or 24 hours of 500 μM and 100 μM HCY treatment respectively. Raw 
264.7 cells receiving anti-EMMPRIN antibody pretreatment with no Hcy treatment 
had significantly reduced (p< .001) CD40 protein expression compared to control. 
Cells receiving pre-treatment with anti-EMMPRIN antibody and treatment with 
Hcy also displayed a decreased expression of CD40 (p< .005). No difference 
was found between the two treatment groups.  J774A.1 cells receiving anti-
EMMPRIN antibody pretreatment with no Hcy treatment had significantly lower 
(p< .005) CD40 protein expression than controls. Cells receiving pre-treatment 
with anti-EMMPRIN antibody and treatment with Hcy also displayed a decreased 
expression of CD40 (p< .005). No difference was found between the two 
treatment groups (Figure 21); n=3.  
 
EMMPRIN Inhibition Reduces ROS Production in J774A.1 Cells 
 Pre-treatment of J774A.1 cells led to a significant decline in ROS 
production when compared to controls. As expected, 100 µM Hcy treatment 
elicited a significant, almost 2 fold, increase in ROS production compared to 
control. However, when Hcy treated cells were pre-treated with anti-EMMPRIN 
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antibody, ROS production was reduced to control levels. This indicates that 
EMMPRIN mediates Hcy induced ROS production in J774A.1 macrophages 
(Figure 22); n=3.  
 
Exercise Decreases M1 Macrophage Infiltration in CBS+/- Skeletal Muscle 
 F4/80 is a cell surface protein that is only found on macrophages and 
monocytes. It is commonly used to detect macrophage populations within other 
tissues. TNF-α is present in skeletal muscle, but it has been documented that the 
vast majority of TNF-α expressed in skeletal muscle is produced by 
macrophages (Hamada, Vannier, Sacheck, Witsell, & Roubenoff, 2005). Co-
localization of F4/80 and TNF-α is indicative of an M1 macrophage population 
since TNF-α is only expressed by M1 macrophages.  Immunohistochemistry for 
co-localization of TNF-α and F4/80 protein expression in gastrocnemius muscle 
sections indicated that TNF-α and F4/80 protein expression were significantly 
increased in CBS +/- mice when compared to C57 controls and exercise 
intervention caused a significant decline in CBS +/- TNF-α expression.  Although 
F4/80 expression did not significantly decrease in CBS +/- mice with exercise, it 
was no longer significantly different from C57 control values, indicating a slight 
reduction in the number of macrophages.  Although TNF-α demonstrated a slight 
decline in C57 mice with exercise, the values were not significant when 
compared with C57 control. No changes in F4/80 protein expression were 
observed in C57 mice with exercise (Figure 24); n=4.  
89 
 
(Winchester, Veeranki, Givvimani, & Tyagi, 2015) 
Figure 17: Hcy increases EMMPRIN expression in macrophages.  EMMPRIN 
protein expression is significantly increased in A) Raw 264.7 cells and B) 
J774A.1 cells by 24 hours of 500µM or 100µM Hcy treatment, respectively. 
Bands were quantitated using densitometry.  Data is presented as the means + 
SEM. n = 3;  p< 0.001; p< 0.05 respectively. 
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(Winchester et al., 2015) 
Figure 18: Hcy increases ROS production in macrophages.  ROS production 
is significantly increased in A) Raw 264.7 cells and B) J774A.1 cells by 24 hours 
of 500µM or 100µM Hcy treatment, respectively. DCFDA assay was used to 
detect ROS production.  Data is presented as the means + SEM. n = 3;  p< 0.05; 
p< 0.01, respectively.  
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(Winchester et al., 2015) 
Figure 19: Hcy increases MMP-9 expression in macrophages.  MMP-9 
expression is significantly increased in A) Raw 264.7 cells and B) J774A.1 cells 
by 24 hours of 500µM or 100µM Hcy treatment, respectively. 
Immunohistochemistry was used to detect MMP-9.  Data is presented as the 
means + SEM. n = 3;  p< 0.05; p< 0.05, respectively.  
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(Winchester et al., 2015) 
Figure 20: Hcy causes macrophages to shift towards an M1 phenotype.   
CD40 protein expression, a marker for M1 macrophages, is significantly 
increased in A) Raw 264.7 cells and B) J774A.1 cells by 24 hours of 500µM or 
100µM Hcy treatment, respectively. Quantification was performed through 
densitometry.  Data is presented as the means + SEM. n = 3;  p< 0.0001; p< 
0.05, respectively.  
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(Winchester et al., 2015) 
Figure 21: Inhibition of EMMPRIN prevents M1 macrophage shift.              
CD40 protein expression, is significantly increased in A) Raw 264.7 cells and B) 
J774A.1 cells by inhibition of EMMPRIN with or without 24 hours of 500µM or 
100µM Hcy treatment, respectively. Quantification was performed through 
densitometry.  Data is presented as the means + SEM. n = 3;  p< 0.001; p< 
0.005, respectively for Ab and Hcy 500µM + AB groups vs control in Raw 264.7 
cells.  p< 0.005; p< 0.005, respectively for Ab and Hcy 100µM + AB groups vs 
control in J774A.1 cells.   
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Figure 22: Inhibition of EMMPRIN decreases ROS production in 
macrophages.  ROS production is significantly decreased in J774A.1 cells by 
inhibition of EMMPRIN with or without 24 hours of 100µM Hcy treatment. 
Quantification was performed through densitometry.  Data is presented as the 
means + SEM. n = 3;  p< 0.001, 0.05 and 0.0005 for Hcy 100µM vs Control, Ab 
vs Control and Hcy 100µM + Ab vs Hcy 100µM, respectively. 
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(Winchester et al., 2015) 
Figure 23: Schematic representation of M1 shift through Hcy treatment. 
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Figure 24: Exercise decreases the number of M1 macrohpages in CBS +/- 
skeletal muscle.  TNF-α (M1) and F4/80 (macrophage marker) expression are 
increased in CBS +/- skeletal muscle. Exercise decreases TNF-α expression in 
CBS +/- mice, indicating a lower population of M1.  Data is presented as the 
means + SEM. n = 4; p< 0.05 for CBS NE vs C57 NE for F4/80. p< 0.01, 0.01 for 
CBS NE vs C57 NE and CBS ET vs CBS NE, respectively, for TNF-α. 
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DISCUSSION 
The primary finding of this present study is that Hcy treatment causes 
macrophages to differentiate into a “classically activated,” M1 phenotype as 
determined by increased CD40 and MMP-9 expression, as well as elevated ROS 
production.  It was found that inhibiting EMMPRIN activity, an inducer of MMP-9, 
resulted in reduced levels of CD40 in murine macrophages. This finding suggests 
that Hcy induced macrophage differentiation into M1 phenotype is facilitated, at 
least in part, by an EMMPRIN mediated pathway.  
Due to its strong association with a variety of pathological conditions, 
many of the consequential effects of HHcy are well-explored (Bortolotto et al., 
1999; Naess et al., 2013; Signorello et al., 2007; Tyagi et al., 2005; Veeranki & 
Tyagi, 2013; Zheng et al., 2013). Hcy associated vascular inflammation and 
remodeling is largely due to increased ROS (Hayden & Tyagi, 2004; Signorello et 
al., 2007) and MMP-9 production (Moshal et al., 2006; Tyagi et al., 2009) as well 
as an inhibition of peroxisome proliferator-activated receptor-γ (PPAR-γ), a pro-
antioxidant (Mujumdar et al., 2002). MMP-9 is activated by Hcy through an 
extracellular signal-regulated kinase (ERK) pathway in vascular endothelial cells 
(Moshal et al., 2006; Tyagi et al., 2009) and is thought to be a primary factor in 
vascular remodeling and arterial stiffness (Onal et al., 2009; Wiernicki et al., 
2011; Yasmin et al., 2005).  However, studies have shown that extracellular 
matrix metalloproteinase inducer (EMMPRIN) activation not only correlates with 
MMP activity, but may be largely responsible for increased synthesis of MMP-9 
(Ge et al., 2007; Major et al., 2002; Reddy et al., 2010; Yoon et al., 2005; Zhu et 
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al., 2005).  It was found that co-localization of macrophages with EMMPRIN and 
MMP-9 occurs in areas of vascular inflammation. Wang et al. suggest that Hcy 
elicits monocyte chemotaxis through induction of monocyte chemoattractant 
protein-1(Wang et al., 2001). Moreover, it was found that a high concentration of 
Hcy enhances MMP-9 production in murine macrophages (Lee et al., 2012). 
These findings led to further investigations to determine whether a pathological 
concentration of Hcy leads to macrophage differentiation into the classically 
activated, M1 phenotype.  
CD40, a co-stimulatory protein, is a commonly used marker of M1 
macrophages that has been described as a prevalent indicator of the M1 
phenotype (Aron-Wisnewsky et al., 2009; Munder et al., 1998; Vogel et al., 
2013). The findings that a pathological dose of Hcy induces CD40 and MMP-9 
protein expression in both J774A.1 and Raw 264.7 murine macrophage cell lines 
suggest that Hcy is causing a shift towards the M1 phenotype. Our data 
corresponds with another study which demonstrates that Hcy enhances MMP-9 
production in J774A.1 cells via ERK and Akt signaling pathways (Lee et al., 
2012).   Interestingly, other studies demonstrate that the pro-inflammatory 
cytokine, IL-18, induces MMP-9 in cardiomyocytes via EMMPRIN activation of a 
PI3K dependent Akt pathway (Reddy et al., 2010; Weisser et al., 2013).  The 
present study demonstrates that 0.1 or 0.5 mM Hcy treatment significantly 
induces EMMPRIN protein synthesis in both J774A.1 and Raw 264.7 
macrophages respectively.  It has been established that EMMPRIN induction is 
strongly associated with inflammatory conditions. EMMPRIN is readily expressed 
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on human carcinoma cell surfaces, atheromas, pro-inflammatory cytokine 
stimulated bone marrow monocytes and in atherosclerotic carotid lesions 
(Gabison, Hoang-Xuan, Mauviel, & Menashi, 2005; Guo et al., 2000; Major et al., 
2002; Yoon et al., 2005). Due to its close association with these inflammatory 
pathologies, I believe that EMMPRIN is at least partially involved in macrophage 
differentiation into the M1 phenotype. To verify this, the effects of EMMPRIN 
inhibition on CD40 expression were examined.  As hypothesized, the inhibition of 
EMMPRIN led to a decreased induction of CD40 in both murine macrophage cell 
lines, with and without Hcy treatment. This suggests that M1 differentiation by 
Hcy is at least partially reliant upon an EMMPRIN mediated pathway.   
Homocysteine is associated with increased ROS production in various cell types 
due to its auto-oxidative properties and through the production of mixed 
disulfides (Hayden & Tyagi, 2004; Signorello et al., 2007). Interestingly, elevated 
oxidative stress levels may result in a destructive M1 macrophage phenotype, as 
detected by increased release of iNOS, TNF-α and pro-inflammatory cytokines. 
Furthermore, it was found that increased EMMPRIN expression, resulting in 
activation of MMP-9 and other inflammatory factors, is induced by elevated ROS 
production (Siwik et al., 2008; Yuan et al., 2010).  This supports the findings that 
Hcy treatment results in an M1 macrophage phenotype through EMMPRIN, 
leading to increased ROS production.  
M1 macrophages are known to fight infections, cause neurotoxicity and 
exacerbate atherosclerosis (El Hadri et al., 2012; Kigerl et al., 2009; Tavakoli & 
Asmis, 2012). These tasks are accomplished through the release of pro-
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inflammatory cytokines and MMP-9 as well as increased reactive nitrogen and 
oxygen species production (de Pinho et al., 2014; Nishi et al., 2008; Sica & 
Mantovani, 2012; Weisser et al., 2013; Woo et al., 2004).  This study further 
validated the Hcy induced shift towards the M1 phenotype by demonstrating 
significantly increased ROS production in Hcy treated murine macrophages 
through a DCFDA assay. Furthermore, it was demonstrated that inhibition of 
EMMPRIN led to a significant reduction in ROS production in and that the effects 
of HHcy on ROS production were completely mitigated when EMMPRIN was 
blocked.  These findings agree with a study by El Hadri et al., which 
demonstrates a predominant population of M1 macrophages in severe 
atherosclerotic lesions of ApoE2.Ki mice (El Hadri et al., 2012) that are reliant on 
ROS production. These mice were challenged with lipopolysaccharide (a known 
inducer of M1) for 5 weeks, causing them to develop atherosclerotic lesions. 
However, when treated with thioredoxin-1, an anti-oxidative protein, the 
macrophages in the lesions shifted predominantly to the M2 phenotype and the 
area of aortic lesion was significantly reduced.  The present study, which 
suggests that CBS+/- gastrocnemius muscle has a greater M1 macrophage 
population and that the number is reduced by exercise, is further supported by 
the concept that anti-oxidative proteins cause a shift in macrophage phenotype 
towards M2. Exercise is known to increase cellular anti-oxidative capacity, which 
in turn helps to reduce muscular inflammation (Vincent et al., 2006). Decreased 
levels of muscular inflammation with exercise in CBS +/- mice would explain the 
observed reduction in M1 macrophage content in the CBS +/- skeletal muscle 
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after training.  Although was an observed decreased concentration of M1 
macrophages in CBS +/- mice with exercise, it is not surprising that there was not 
a significant reduction in overall macrophage presence (F4/80). It has been 
documented that macrophages are capable of shifting phenotype within the 
skeletal muscle, depending on the environment (Arnold et al., 2007; Chazaud et 
al., 2009). Therefore, it is very plausible that the present M1 macrophages shifted 
into an M2 phenotype or just became relatively inactive.  Further research is 
clearly needed to determine the changes occurring with intramuscular 
macrophage populations with exercise and HHcy.  
In summary, the present study demonstrates that Hcy causes murine 
macrophages to shift into a classically activated M1 phenotype as determined by 
CD40 expression. This stimulates EMMPRIN and MMP-9 synthesis as well as 
increased ROS production. Furthermore, it was found that inhibition of EMMPRIN 
leads to decreased CD40 in these cells, indicating a shift away from the M1 
phenotype. Moreover, it is apparent that HHcy causes a greater M1 macrophage 
population in the skeletal muscle and that this population shifts to a different 
phenotype with exercise intervention.  Altogether, these results suggest that Hcy 
promotes an M1 macrophage phenotype through an EMMPRIN mediated 
pathway and that exercise can mitigate the inflammatory state associated with 
HHcy and M1 macrophages.  
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CHAPTER VI 
SUMMARY, CONCLUSION AND FUTURE DIRECTIONS 
 
 Hyperhomocysteinemia has been widely implicated in the development of 
cardiovascular diseases such as hypertension, atherosclerosis, heart failure and 
diabetes (Bortolotto et al., 1999; Signorello et al., 2007; Sutton-Tyrrell et al., 
1997; Wiernicki et al., 2011; Zheng et al., 2013). Elevated levels of inflammation, 
including increased MMP-9 and ROS production are hallmarks of HHcy (Lee et 
al., 2012; Signorello et al., 2007; Tyagi et al., 2009). Clinical studies of patients 
with genetic defects that cause HHcy, such as MTHFR or CBS deficiency, 
display decreased bodyweight and skeletal muscle mass (Kalra et al., 1985; 
Kanwar et al., 1976).  Research has demonstrated that HHcy translates to 
impaired muscular strength and elicits functional limitations in humans and 
animals (Swart et al., 2013; Veeranki et al., 2015). With this knowledge, there is 
sufficient evidence that suggests that HHcy may induce chronic inflammation in 
skeletal muscle leading to muscular dysfunction. However, the molecular 
changes and mechanisms associated with this are still very unclear. 
Furthermore, it has been demonstrated that exercise is capable of reducing 
plasma Hcy levels (Neuman et al., 2013; Randeva et al., 2002). Therefore, 
exercise would serve as a promising intervention for individuals with HHcy and 
HHcy related pathologies. 
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 In the first set of experiments it was found that HHcy led to decreased 
body mass and skeletal muscle perfusion in CBS +/- mice. It was found that the 
skeletal muscle of these mice have significantly higher collagen deposition in the 
skeletal muscle, indicating fibrosis, as well as increased levels of the growth 
inhibiting factor, myostatin.  This study showed that HHcy led to inflammation of 
the skeletal muscle and that the remodeling likely occurs through elevated MMP-
9 levels via EMMPRIN induction. Interestingly, our CBS/MMP-9 double KO 
mouse model did not display any of the pathologies that are apparent in CBS +/- 
mice, indicating that HHcy elicits most of its effects through MMP-9.  Moreover, 
this study demonstrates that exercise training can completely mitigate most of 
these physical and molecular changes found in CBS +/- mice.  
 In the second set of experiments, it was found that treatment of 
macrophages with Hcy caused differentiation into a classically activated, M1 
phenotype, which is associated with increased MMP-9 and ROS production. It 
appears that HHcy induction of the M1 phenotype is EMMPRIN dependent, since 
EMMPRIN induction prevented the M1 switch. Furthermore, this study 
demonstrated that CBS +/- mice have a greater concentration of macrophages in 
their skeletal muscle and that a great number of these macrophages were of the 
M1 phenotype. Although exercise did not significantly decrease the total 
macrophage concentration within the skeletal muscle, it was able to significantly 
reduce the number of M1 macrophages present, indicating a lower state of 
inflammation and adverse remodeling.  Although the data is significant and 
conclusive, our study was limited. A longer exercise protocol as well as different 
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modalities of exercise would help make greater comparisons for this study. Also, 
macrophages were not isolated from the skeletal muscle, so limited conclusions 
could be made based on the IHC for co-localization of F4/80 and TNF-α for 
indication of M1 macrophages. Isolation of macrophages from the skeletal 
muscle could lead to more conclusive data.  
 
Future Directions:  
Skeletal muscle remodeling involves a great number of cell types and 
secreted factors that regulate growth, repair and fibrosis of the skeletal muscle 
ECM.  The primary focus of this study was to determine if HHcy promotes 
skeletal muscle fibrosis through induction of MMP-9 and the M1 macrophage 
phenotype and whether or not exercise can mitigate the effects of HHcy. 
Although this study was able to demonstrate these effects, there are many other 
factors and signaling pathways that need to be determined to devise the 
mechanism through which HHcy causes skeletal muscle dysfunction.   
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 Perform standard fitness tests on clients to determine health status. 
 
Student Assistant, Purdue University WorkLife Programs 
 West Lafayette, IN 02/07 – 07/07 
Assisted with overall organization of a program titled Targeted 
Communication. 
Helped organize mass mailings for the Targeted Communication program. 
 Helped to lead patrons through a walking program. 
 Assisted in numerous other office related tasks 
 
Head Fitness Center Supervisor, Purdue University Colby Fitness 
Center 
West Lafayette, IN    01/05 – 11/05 
Organized the fitness center staff duties and schedules 
Performed duties such as Payroll and kept track of the number of patrons. 
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Personal Trainer and Supervisor, Harrison Barbell Fitness Center 
Harrison, OH    05/05 – 08/05 
Interacted with clients by providing a solid workout schedule and diet. 
Instructed the patrons with proper form and technique of exercises.  
Assisted in the organization of the fitness center and memberships. 
 
 
Teaching Experience 
 
 Guest Lecturer in Exercise Physiology, Hanover College. 
 Hanover, IN   10/23/14 and 10/3/13 
I provided guest instruction to an undergraduate pathophysiology class. In 
October of 2014 the topic of discussion was inflammation induced 
pathologies of skeletal muscle and vascular dysfunction. In October of 
2013 I provided a guest lecture about iron metabolism and reactive 
oxygen production.  
 
Teaching Assistant for Undergraduate Anatomy and Physiology, 
University of Louisville 
Louisville, KY 08/09 - 05/10 
My role as the teaching assistant was to grade assignments and proctor 
examinations. During this time I gave several presentations on 
endocrinology.  
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Teaching Assistant for First Year Graduate Exercise Physiology 
Laboratory Methods Course, University of Louisville 
Louisville, KY 08/09 – 12/09 
This course was divided into two parts: a lecture section and a laboratory 
section. I directly provided instruction for the laboratory section 
demonstrating proper protocols and techniques utilized in the exercise 
physiology laboratory.  
 
 
Publications 
 
Winchester, L., Veeranki, S., & Tyagi, S.C., Homocystiene Elicits and M1 
Phenotype in Murine Macrophages Through an EMMPRIN Mediated 
Pathway. Canadian Journal of Physiology and Pharmacology. 2015, Mar 
31:1-8. 
Givvimani, S., Kundu, S., Pushpakumar, S., Doyle, V., Narayanan, N., 
Winchester, L., Veeranki, S., & Metreveli, N. Hyperhomocysteinemia a 
Missing Link to Dysfunctional HDL via Paraoxanase-1. Canadian Journal 
of Physiology and Pharmacology. 2015 Apr 15:1-9.  
 
Veeranki, S., Winchester, L., & Tyagi, S.C. Hyperhomocysteinemia 
(HHcy) associated skeletal muscle weakness involves mitochondrial 
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dysfunction and epigenetic modifications. Biochimica et Biophysica Acta. 
2015 May;1852(5):732-41. 
 
Winchester, L., Veeranki, S., Givvimani, S., & Tyagi, S.C. 
Exercise mitigates the adverse effects of hyperhomocysteinemia 
on macrophages, MMP-9, skeletal muscle, and white adipocytes. 
Canadian Journal of Physiology and Pharmacology. 2014 Jul;92(7):575-
82  
 
Lambert, C.P., Winchester, L., Jacks, D.A., & Nader, P.A. Sex 
Differences in Time to Fatigue at 100% VO2 peak When Normalized for 
Fat Free Mass. Research in Sports Medicine: An International Journal. 
2013; 21(1): 78-89. 
 
Topp, R., Winchester, L. J., Sannes, S. H., Mink, A. M., Kaufman, J. S., & 
Jacks, D. E. A Comparison of Ice with 3.5% Menthol Gel on Blood Flow 
and Muscle Strength of the Lower Arm.  Journal of Sport 
Rehabilitation.  2011; 20: 355-366. 
 
Topp, R., Winchester, L. J, Schilero, J. & Jacks, D. E. Effect of Topical 
Menthol on Ipsilateral and Contralateral Superficial Blood Flow Following a 
Bout of Maximum Voluntary Muscle Contraction. International Journal of 
Sports Physical Therapy, 2011 Jun: 6(2): 83-91. 
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Poster Presentations 
 
Exercise Mitigates the Deleterious Effects of Hyperhomocysteinemia on 
Muscular Function and Inflammation. Lee J. Winchester, MS, Sudhakar 
Veeranki, PhD, Sathnur Pushpakumar, MD, PhD, Srikanth Givvimani, MD, 
PhD, and Suresh C. Tyagi, PhD. September 2014. ACSM Integrative 
Physiology of Exercise Conference. Miami Beach, FL.  
 
Reversing Increased M1/M2 Macrophage Ratio in Hyperhomocysteinemic 
Skeletal Muscle With Exercise.  Lee J Winchester, MS, Sudhakar 
Veeranki, PhD, Sathnur Pushpakumar, M.D., Ph.D., and Suresh C. Tyagi, 
PhD. April 2014. Experimental Biology Conference. San Diego, CA.  
 
Reversing Hyperhomocysteinemia Induced Skeletal Muscle Myopathy 
With Regular Exercise. Lee J Winchester, Sudhakar Veeranki and 
Suresh C. Tyagi. March 2014. Kentucky Physiological Society Annual 
Meeting. Louisville, KY 
Induction of Ferritin by Small Molecules may Have Cytoprotective Effects. 
Winchester, L., Trent, J., Lamont, G., & Eaton, J.W.  October 2013.  
James Graham Brown Cancer Center Retreat, University of Louisville 
Louisville, KY. 
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Activities and Honors  
 
Graduate Student Council Representative 
In 2010 I served as the student representative for the Health and Sports 
Sciences Department on the Graduate Student Council at the University of 
Louisville. Meetings discuss issues related to graduate student activities, 
primarily travel funds. In February 2009, I organized the graduate student 
funding procedures for the Exercise Physiology department’s trip to the 
Southeast ACSM conference. 
  
 
Student Lab Assitant, Purdue University Wastl Exercise Physiology 
Lab 
During my undergraduate career I assisted with research in the Wastl 
Exercise Physiology lab in the basement of Lambert Hall, primarily dealing 
with carbohydrate studies. I assisted in preparation procedures as well as 
various techniques during VO2 max testing, including blood collection and 
analysis. 
Professional Memberships 
  
 American Physiological Society  
 Graduate Student Member since 2013 
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 American College of Sports Medicine 
 Graduate Student Member since 2008 
 
 
